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MOTIVATIONS OF THE THESIS 
 
The objective of this Thesis is the design, development and characterization of a biomimetic system 
to be used as a tool to simulate the intestinal barrier in vitro. 
The in vitro mimicking of a biological system allows to establish a model of a phenomenon occurring 
in vivo. This can thus be analyzed singularly and independently from the surrounding environment, 
which would imply a substantial increase of the parameters to be considered. By using a proper in 
vitro model it is possible to study the response of the system to precise stimuli, thus allowing the 
prediction of a series of events subsequent to the tuning of certain conditions. 
The system proposed in this Thesis is a biohybrid tool, based on a porous polylactid acid nano- 
membrane, which constitutes the interface between intestinal Caco-2 cells and beating 
cardiomyocites. The aim is to obtain a chip, useful to test drugs, nanoparticles and other substances, 
in terms of their toxic and/or therapeutic effects. The work deals with a recent research trend, 
aimed at engineering on-chip organs and tissues, based in most cases on the coupling of 
nanostructured materials and cell cultures. These systems are envisaged as tools to complement or 
to replace tests on animals, widely used at present for toxicological analysis and drugs testing. 
Worldwide, the estimated number of vertebrates employed for in vivo experiments ranges between 
10 and 100 millions per year. 
In 1959, Russel and Burch proposed the 3R rule, based on the following fundamental principles: 
 
• Replacement: replacement of animal testing with alternative methods; 
• Reduction: reduction of the number of animals employed; 
• Refinement: improvement of animals living conditions. 
 
The above-mentioned rule was introduced by the European Union, within the 2010/63/UE directive, 
focused on the safeguard of animals employed for scientific purposes. 
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From 2009 animal tests were banned in Europe, as a means to test cosmetic products. From 2013, 
it is also prohibited, in Europe, to sale cosmetic products containg ingredients tested on animals, all 
over the world. 
In addition to ethical concerns, in vivo tests are also characterized by long time durations and high 
costs, thus raising the need of effective alternatives, in vivo and in silico. The in vitro tool developed 
in this Thesis could be useful for the study of specific diseases related to dysfunctions in intestinal 
absorption mechanisms. Intestinal malabsorption is a syndrome characterized by an incomplete 
absorption of nutrients. It can be: 
• GENERALIZED: if the absoption dysfunction involves just proteins, sugar and fat and causes    
diarrhea with fat in the feces; 
• SELECTIVE: if the absorption dysfunction involves only one class of nutrients; 
• TOTAL: it the absorption dysfunction involves the whole small intestine and always causes 
diarrhea; 
• PARTIAL: if the absorption dysfunction involves only a specific intestinal tract and it does 
not cause diarrhea. 
Intestinal absorption dysfunctions can also be incidental to diseases of other organs such as the 
exocrin pancreas. It is possible to discriminate among the following cases: 
• absorption dysfunction caused by a predominant endoluminal deficiency: of pancreatic ori-
gin (chronic pancreatitis, pancreas cancer, cystic fibrosis); of biliary origin and due to 
enzyme inactivation; 
• absorption dysfunction derived from a predominant parietal defect: celiac disease, Crohn's 
disease, amyloidosis etc. The absorption insufficiency can arise from a reduction of the 
available absorption surface (in case of extended resection),  from an altered absorption 
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surface (celiac disease, Crohn's disease), from unsufficient blood supply, from lymph 
outflow obstructed in its path and from intracellular transport selective defects. 
Taking into account these considerations, the purpose of this work arises from the need to have a 
tool that allows to model the physiological and pathological features of intestinal barrier and, on 
the other hand, of the absorption mechanisms through it. A commonly accepted intestinal 
absorption model consists of a layer of Caco-2 cells, extracted from the human colon and cultured 
on a polycarbonate membrane, within a transwell. In this system, the substances to be tested are 
provided in correspondence of the apical side of the monolayer and the compounds filtered through 
the cells are monitored in correspondence of the basolateral side. The traditional model has some 
limitations, in terms of the expression of particular proteins, of cellular morphology, but above all 
for the lack of peristalsis, which implies an altered permeability. Taking into account the intrinsic 
limitations of the traditional models and the lack of suitable technologies and procedures in the 
state of the art, this work aims at: 
⦁ developing a ultra-thin polymeric membrane provided with highly regular pores (conferring 
high permeability to the system) and showing high biocompatibility, thus allowing the culture 
of intestinal Caco-2 cells and cardiomyocytes. This will allow, with few evolutions of the device, 
to replace monocultures with co-cultures of these cells; 
⦁ developing a biohybrid tool that would be able, in future evolutions of the system, to gene-
rate contractile movements which simulate in vitro the peristalsis of the intestine occurring in 
vivo. 
 
The Thesis is based on a multidisciplinary research effort, combining know-how and technologies 
typical of different fields, such as materials science, molecular biology and micro-/nano-fabrication. 
It represents properly the interdisciplinarity that is typical of the bioengineering field, aiming at 
developing innovative systems for diagnosis and therapy. 
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1. INTRODUCTION 
 
1.1 INTESTINE ANATOMY AND PHYSIOLOGY: 
 
Before specifically describing intestine, an overview of the whole apparatus it belongs to and a 
sketch of its functions are desirable. The attention was focused on those functions accomplished by 
the organ and targeted by the in vitro model proposed. In this Thesis, the digestive apparatus, which 
includes also the intestinal tract, accomplishes the following key processes [16]: 
• DIGESTION: chemical and mechanical fragmentation of food in smaller units, able to pass 
through the intestinal epithelium and thus to enter into the organism. 
• ABSORPTION: either active or passive transport of substances from the lumen of the gastro-
intestinal tract to the extracellular fluid. 
• MOTILITY: muscular contraction, causing the movement of substances along the 
gastrointestinal tract. This movement has to guarantee an advancement of food within the 
intestinal lumen lasting a time interval sufficient to allow the digestion of nutritious 
substances and promotes simultaneously their absorption through the intestinal barrier. 
• SECRETION: transport of water and ions from the extracellular fluid to gastrointestinal 
lumen, and secretion of substances from the cells of the digestive canal. The secretion is 
controlled in order to guarantee the supply of proper quantities of digestive enzymes, so 
that the food within the gastrointestinal tract can be fragmented in absorbable forms. 
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1.1.1 DESCRIPTION OF THE INTESTINAL TRACT: 
 
 
Figure 1.1: Depiction of the intestine components: small intestine, large intestine, rectum and colon. 
The small intestine is conventionally divided into three parts: duodenum, jejenum and ileum 
(jejenum and ileum constitute the mesenteric part). They are located in the abdominal cavity and 
the blood vessels, connecting the small intestine to the rest of the body, go through the mesentery. 
Figure 1.1 depicts the overall intestine structure, involving small intestine, large intestine, rectum, 
colon and anus. 
The small intestine is composed of four concentric tunicae, as shown in Figure 1.2 and Figure 1.3. 
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Figure 1.2: Small intestine structure. 
 
Figure 1.3: Small intestine structure, showing a surface topography characterized by crypts and villi. 
The tunicae are the following: 
• TUNICA SEROSA: constituted by the peritoneum (a layer of flat endothelial cells that lay 
on an well-grown elastic membrane) and the underlying subserosa (thin layer of 
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connective and adipose tissue containing blood and lymph vessels). 
• TUNICA MUSCULARIS: consisting of two layers of smooth muscle cells: an external 
longitudinally oriented one and an internal (thicker) circularly oriented one. 
• TUNICA SUBMUCOSA: composed of connective tissue, which is very rich of blood and 
lymph vessels. 
• TUNICA MUCOSA: characterized by three layers. From the external to the internal side, 
they are: 
                       
                 
• Muscolaris mucosae: thin layer of smooth muscle cells, mainly longitudinally oriented. 
Intestinal villi emerge from this layer. 
 
• Lamina propria: it constitutes the villus axis; it brings in the villus the vascular structures 
and the thin muscle fibers that allow villus contraction. 
 
• Epithelial layer: villus lining layer. 
 
 
Intestinal villi are protrusions that extend perpendicularly to the small intestine mucosa, thus 
confering it a velvety aspect. Villi are characterized by heights ranging between 320 and 570 µm and 
thicknesses of about 85-140 µm. Microvilli rise perpendicularly from the villi tips and they reach a 
maximum height of about 1.3 µm and thicknesses of about 0.2 µm. Microvilli increase the intestinal 
absorbing surface of about 20 times. The typical structure of the intestinal barrier, formed of 
superficial projections (villi and microvilli) is shown in Figure 1.4. 
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Figure 1.4: Intestine superficial protrusions (villi and microvilli) that increase the absorption of substances through the 
intestinal barrier. 
 
An important characteristic, which allows the transit of bio-compounds within the gastrointestinal 
tract (GI) is the intestinal motility. Ater its evacuation from the stomach, the chyme enters in the 
small intestine and it is pushed ahead through the duodenum. Muscle twitches allow chyme mixing 
with enzymes and its exposure to the absorbing mucosa. The two main types of intestinal motility 
are: 
Segmenting contractions: localized contractions, involving the whole circumference of the 
small intestine muscular tunica and lasting a few seconds. The contractions take in the 
lumen and tend to divide its contents. In general they are stationary and localized in a 
specific intestinal tract, but they could also be propellant and continuing for some 
centimeters. Segmenting contractions constitute the most common type of intestinal 
motility. It is possible to distinguish simple segmenting contractions, characterized by an 
irregular pattern, and rhythmic segmenting contractions. 
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Peristaltic contractions: they have a length of about 4-5 cm and they propagate along a short 
tract of the intestinal loop with a speed of 1-2 cm per minute. The speed is higher within 
the duodenum and it decreases within the ileum. Peristaltic contractions allow the 
movement of intestinal contents towards the distal intestinal parts.  Peristalsis is a traveling 
contraction wave produced by the contraction of circular muscles upline, the contraction of 
longitudinal musculature and, parallely, the relaxation of the circular musculature 
downstream respect to the stimulation location. 
Figure 1.5 illustrates the difference between the segmenting and the peristaltic contractions, 
previously described. 
 
 
 
Figure 1.5: Representation of the two types of intestinal motility: peristaltic (on the left) and segmenting contractions (on 
the right).   
 
It is necessary to guarantee a sufficiently slow progression of the chyme along the intestine, in order 
to allow the proper absorption through the intestinal barrier. The small intestine receives an average 
of 5.5 liters of food, liquids and secretions and approximately other 3.5 liters of hepatic, pancreatic 
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and intestinal secretions. The total volume of the intestinal lumen is about 9 liters per day. In a day 
additional secretions involve: 
• BICARBONATE: it originates mainly from pancreas; it neutralises the chyme (very acidic) 
which reaches the small intestine from the stomach; 
• BILE: bile salts are essential for fat digestion; 
• MUCUS: secreted by intestinal goblet cells, with a function of protection and lubrication; 
• DIGESTIVE ENZYMES. 
 
Most of the ingoing liquids (about 7.5 liters respect to the 9 liters input initially) are reabsorbed by 
the intestine. Organic nutritious substances and ion transport, which take place mainly in the 
duodenum and in the jejenum, create an osmotic gradient that causes the resulting absorption of 
water. Most of the nutritious substances absorbed enters in intestinal villi capillaries and then in the 
hepatic portal system. The small intestine represents the location where the main part of the 
digestion takes place. The junction between small intestine and colon acts as a sphincter, thus 
regulating the flux of substances from the ileum to the caecum and preventing retrograde transport. 
The sphincter opens when the peristaltic wave, which passes along the ileum terminal part, 
generates a pressure that is sufficient to overcome the sphincter resistance. The colon starts in 
correspondance of the ileum-caecum sphinter and it stops in the rectum (Figure 1.6). 
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Figure 1.6: Large intestine components. 
 
The intestinal barrier ([17]) is the functional unit that guarantees the stable balance between the 
antigen charge of intestinal lumen and the complex immunologic and non immunologic 
organization of the intestinal mucosa. The intestinal barrier accomplishes two key functions for the 
survival of individuals: it allows the absorption of nutritious substances and drugs and it defends 
the organism from penetration of damaging macromolecules. Intestinal flora, mucous layer, 
intestinal epithelium, natural and acquired immunity components, endocrine system, vascular 
lymphatic system and digestive enzymes are essential factors for a proper functioning of the 
intestinal barrier. All of these components are characterized by mutual complex interactions, which 
allow to preserve intestinal barrier capability to prevent systemic transport of damaging substances. 
 
1.1.2 ABSORPTION MECHANISMS OF DRUGS AND NUTRITIOUS SUBSTANCES: 
 
 
The main functions of intestine are digestion and absorption of drugs and nutritious substances. 
They actually pass through the intestinal barrier, acting as a selective porous membrane. Intestinal 
absorption represents the last digestive phase. It determines the transport in the blood flow, 
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through the intestinal walls, of substances obtained from the digestion of macromolecules 
contained in the food. These substances are: mainly glucose (derived from starch and saccharose), 
amino acids (derived from proteins), glycerol and fatty acids (derived from fats), vitamines and salts. 
Most of the absorption takes place through the jejenum and the ileum walls. Small intestine walls 
are shaped in several folded structures covered with thousands of thin projections, called intestinal 
villi. Each villus is 1 mm long and there are about 3000 villi for each cm square. The surface of each 
villus is further increased by the presence of microvilli, produced by superficial protrusions of the 
intestinal villi cladding membrane. The intestine internal surface is characterized by a topography 
with a crypt-villus pattern. This feature promotes intestinal absorption and it is responsible of the 
transport of bio-compouds. 
In correspondence of the crypts, secretion of substances mainly takes place, whereas villi are 
specialized structures responsible for intestinal absorption, as they increase the transport and 
absorption surface available. Molecules pass through microvilli membranes. Each villus is formed of 
a capillary network, in which blood flows. Glucose, amino acids, salts and vitamines are filtered and 
transported into the blood. Intestinal capillaries converge in a blood vessel, the portal hepatic vein, 
which enters into the liver. Figure 1.7 depicts the intestinal barrier surface structure, constituted by 
crypts and villi. 
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Figure 1.7: Intestinal surface topography characterized by crypts and villi. 
Fats follow a different metabolic path. After going though the microvilli membrane, glycerol and 
fatty cluster, reconstituting triglycerides and they are conveyed in lymph vessels. Lymph vessels then 
flow into a single conduct that flows into the circulatory stream. All of the molecules, which derive 
from food digestion are thus released directly or undirectly in the blood. After a first absorption in 
the small intestine, substances continue their path within the large intestine. Here, mucosa glands 
secrete only mucus and not enzymes. Even if the walls are oiled by the mucus, the transit time of 
intestinal contents is rather long: it ranges between 2 and 6-7 hours. In large intestine water and 
mineral salts are absorbed and food which was not digested is eliminated with the faeces. Nutritious 
substances, mineral salts and vitamines are absorbed through the intestinal barrier thanks to one 
or more active transport mechanisms. They are energy-dependent transport processes mediated 
by membrane proteins and they work either against concentration gradient or in absence of 
electrochemical concentration gradient. Intestinal epithelial cells are key mediators for water and 
ions absorption. Macrophages, muscle cells and enteric nervous cells interact with them. 
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Fat assimilation needs integrated processes involving the digestive phase, the following absorption 
phase and the post-absorption phase. Carbohydrates instead, are absorbed only in the small 
intestine in form of monosaccharides. Their absorption requires the presence of a sodium pump 
and of a "carrier protein". Before their absorption they are digested by two enzymes involved in the 
process: pancreatic amylase and intestinal disaccharidase. Protein absorption instead requires an 
extensive hydrolysis phase aimed at reducing them in form of di- or tri- peptides or simple amino-
acids. Proteolysis is carried out in the stomach and in the small intestine mainly thanks to two 
enzymes: trypsin and pepsin. Figure 1.8 depicts the main routes of bio-compounds absorption 
through the intestinal barrier. 
 
 
 
Figure 1.8: Representation of the absorption routes of absorption through the intestinal barrier. 
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Concerning drug absorption, there are different routes, which can be distinguished between  
entheral and parentheral ones. In the case of entheral assumption (enteron is the latin word for 
intestine), the drug is in contact with the digestive channel mucosa, whereas in the case of 
parentheral assumption the drug enters the organism by injection. In relation to the aim of this 
work, we focus mainly on the entheral route. Drug absorbtion is the transport mechanism of the 
drug from its administration site to the circulatory stream. Its speed and efficiency depend on the 
administration route. The intestinal epithelium acts as a selectively permeable barrier, through the 
formation of complex protein-protein networks that mechanically link adjacent cells and seal the 
intercellular space. The protein networks connecting epithelial cells form three adhesive complexes: 
desmosomes, adherens junctions, and tight junctions.  These complexes consist of transmembrane 
proteins that interact extracellularly with adjacent cells and intracellularly with adaptor proteins 
that link to the cytoskeleton [46]. The predominant cell type in all absorbing regions is referred to 
as an enterocyte. Enterocytes are columnar epithelial cells that are bound to their neighboring cells 
at the luminal surface by tight junctions. Their apical cell membranes posses numerous microvilli 
which greatly increase the surface area available for absorption [47]. At various portions of the 
absorbing regions, absorption is favored by mucosal structures such as fenestrations (small holes) 
in the endothelial cells of the capillaries, or pores of different sizes in the membranes of the 
enterocytes. Underlying the lamina propria is a thin layer of smooth muscle, the muscolaris 
mucosae. In regions of active absorption such as the small intestine, the muscular layer appears to 
be related to the rhythmic movements of the villi that agitate the layer of intestinal secretions and 
chyme that are in contact with the epithelium and thus promote absorption. 
Figure 1.9 summarizes the different mechanisms of transport through intestinal barrier. 
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Figure 1.9: Representation of the different transport routes of drugs. 
 Drug transport can be based on one of the following processes: 
PASSIVE DIFFUSION: according to concentration gradient or electrochemical gradient; 
SPECIALIZED TRANSPORT: 
FACILITATED DIFFUSION: water-soluble drugs with molecular diameter higher than 4 Å 
pass through the fat layer by means of carriers (as depicted in Figure 1.10); 
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Figure 1.10: Transport mediated by carriers. 
 
ACTIVE TRANSPORT: requires energy consumption (ATP). 
ENDOCYTOSIS-PHAGOCYTOSIS: water-soluble drugs characterized by large diameters enter  the 
cell by invagination of the cellular membrane and further formation of vescicles (Figure 
1.11). 
 
 
 
Figure 1.11: Transport by endocytosis. 
FILTRATION: drugs pass through the intercellular spaces of capillaries endothelium according to 
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pressure gradient and molecular diameter, independently from their fat solubility, polarity 
and percentage of ionization. 
Most of drugs are absorbed by passive diffusion in their non ionized form. The percentage of the 
available non ionized drug amount depends on two aspects: on the one hand it depends on 
environmental pH, on the other hand it depends on its pKa. pKa is the dissociation costant, which 
refers to the amount of dissociated molecules. In particular it represents the pH that determines 
50% of the molecules dissolved to be in the ionized form. Drugs are shared by the three components 
of the organism: blood, extracellular fluid and intracellular fluid. The amount of drug in each of the 
components depends on their physical and chemical properties. In particular, drug absorption is 
determined by the following causes: 
• Mass action law: according to the theory, a great number of small particles (in particular 
atoms and molecules), even if they are individually characterized by random motion, can 
be attributed to a higher-level model. The resulting overall movement is in fact directional. 
The mass action law states that the speed of a chemical reaction is proportional to the 
concentration of the substances involved. The variation of the amount of products obtained 
is then proportional to the product of reagents activities. 
• Henderson-Hasselbach equation: it describes the derivation of pH as a measure of acidity 
in biological and chemical systems. In fact it represents the relation between pH and acid 
concentration by the use of its pKa (negative logarithm of its acid dissociation constant). 
• Pharmaceutical stage (characterized by the capability of the drug pharmaceutical form to 
release the active principle, which has to be absorbed and submitted to pharmacokinetic 
processes); 
• Particles dimensions (the process of particles absorption is faster or slower according to 
the dimensions of the particles) 
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• Gastrointestinal pH and resistance to gastric pH; 
• Absorbing superficial area; 
• Speed of blood flow; 
• Physical and chemical interactions with intestinal contents, resistance to stomach, 
intestine and intestinal flora enzymes; 
• Gastrointestinal motility; 
• Specialized transport; 
• Enterohepatic circle; 
 
Drugs, which show low solubility in fats, are in general scarcely absorbed by the intestine. However, 
some drugs are absorbed thanks to transport systems based on carrier proteins. Drug absorption 
physiology in the gastrointestinal tract affects the bio-availability of the drug, namely the drug 
fraction entering the systemic circulation. 
1.1.3 INTESTINAL MALABSORPTION DISEASES: 
The in vitro model proposed in this thesis is conceived as a tool aimed at simulating the intestinal 
barrier, both as a permeable route of transport of bio-compounds and drugs, and in terms of its 
physio-pathological features and functioning in the case of malabsorption diseases. In fact, the 
physio-pathological in vitro model proposed is conceived as a useful tool to study malabsorption 
pathologies in terms of their dynamic development and characteristic features, in order to allow 
the development and the optimization of pharmacological focused effects. 
Malabsorption through intestinal barrier can originate from various diseases or their consequences. 
The mechanism can be represented either by a direct alteration of the intestinal absorption or by 
digestive dysfunctions that are responsible of the altered absorption. In succession there are some 
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examples of symptoms typical of intestinal malabsorption diseases. Malabsorption symptoms are 
caused by the effects of osmotically active substances within the GI tract or by nutrient deficencies 
that this condition implies. The symptoms are weight loss, wrist-breech spasms, absence of 
tendinous reflexes, cutaneous ecchymosis, flatulence, abdominous spread and problems due to the 
increase of the intestinal mass and to gas production. Secondary nutrient deficits, instead, arise 
proportionally to the severity of the primary disease and they depend on the specific area of the GI 
tract affected. Many patients affected by malabsorption are often anaemic, normally because of 
iron deficiencies. Iron deficit arises usually in the case of celiac disease and of gastrectomy. 
Malabsorption diagnosis is mainly based on fecal fats measurements; it represents the most reliable 
test allowing a credible diagnosis. Other diagnostic evaluations are based on faeces inspection and 
faeces microscopic exam. The faeces, in fact in the case of intestinal malabsorption pathologies, are 
characterized by a typical well-identifiable appearence: for example the presence of not digested 
food fragments suggests either extreme intestinal ipermotility or short intestine syndrome. Another 
useful screening method is based on absorption tests. For example, d-xylose absorption test 
represents an indirect bur rather specific measurement method of the absorption through small 
intestine proximal part. Small intestine biopsy furthermore at the jejenum level is a routine 
procedure that allows to extract jejenum succus, which is then subjected to a microbiological 
analysis of intestinal flora. Endoscopic biopsies are also very useful, if executed in the second 
segmentum of the duodenum. Duodenum histologic analysis allows specific diagnosis of various 
intestinal malabsorption diseases, in particular concerning the celiac disease, white diarrhoea and 
herpetiformis dermatitis, characterized by intestinal villi atrophy. Intestinal malabsorption can be: 
• GENERALIZED: in this case it regards proteins, sugar and fats and it causes diarrhoea and 
fat within the faeces; 
• SELECTIVE: in this case it regards a single class of nutritious substances; 
• TOTAL: in this case it regards the entire small intestine and it always causes diarrhoea; 
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• PARTIAL: in this case it regards a single intestinal tract; 
It is possible to discriminate also between: 
• MALABSORPTION DUE MAINLY TO ENDOLUMINAL DEFICIENCIES: it can be of pancreatic 
origin, of bilious origin and it could be also due to enzymatic inactivation; 
• MALABSORPTION DUE MAINLY TO PARIETAL DEFICIENCIES: celiac disease, Crohn's disease, 
lymphoma, amyloidosis etc. Intestinal absorption inadequacy can derive from a reduction 
of the absorption surface (extended resections), from alterations of the absorption surface 
(celiac disease, Crohn's disease, lymphoma), from insufficient blood supply, from lymph 
obstructed flow path and from intracellular transport selective deficiencies. 
Intestinal malabsorption diseases, as in the case of celiac disease, are supposed to be also of genetic 
origin. Malabsorption causes and the responsible genes are still under investigation, there are in 
fact many research efforts aimed at discovering the disease-causing factors, not fully understood so 
far. 
Malabsorption is a term that refers to the following features: 
• inadequate food digestion; 
• insufficient nutrients absorption through intestinal cells; 
• alteration of nutrients transport along lymphatic vessels. 
Malabsorption causes derive mainly from the reduction of enzymes that are necessary to guarantee 
food digestion and absorption. Below some diseases that cause dysfunctions of the absorption 
mechanisms through the intestinal barrier are described. 
Celiac disease is an autoimmune, multi-organ disease, characterized by the production of auto-
antibodies and by the appearing of intestinal damages caused by gluten ingestion in individuals with 
genetic alterations. The celiac patient is characterized by a total and permanent intolerance towards 
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gluten, a protein contained in many kinds of food. Gluten determines intestinal mucosa atrophy and 
it can cause also Durhing herpetiformis dermatitis consisting of cutaneous lesions in 
correspondance of limbs, trunk, glutei and head. Figure 1.12 below depicts the difference in the 
appeareance of intestinal mucosa in the case of a healthy individual and in the case of a celiac one. 
The celiac individual is characterized by an evident villi atrophy. 
 
 
Figure 1.12: Comparison between the appeareance of intestinal mucosa in the case of an individual which is not affected 
by intestinal malabsorption (left), and in the case of celiac patient; the celiac patient is characterized by an evident villi 
atrophy. 
 
In order to diagnose celiac disease, it is fundamental to evaluate villi atrophy by means of 
histological analyses, thanks to intestinal biopsy obtained during gastroscopy. Because of the high 
predominance of the celiac disease within the population (1%), it represents one of the main causes 
of malabsorption. Intestinal malabsorption diseases include also the intolerance towards 
carbohydrates, due to galactase deficiencies. In fact, galactase is one of the enzymes that are 
responsible of the scission of disaccharides into monosaccharides within the small intestine. The 
disaccharides which are not separated remain within the intestinal lumen, they hold liquids within 
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because of homeostasis, causing diarrhea and abdominal spread. 
 Another disease that provokes intestinal absorption deficiencies is white diarrhea (sprue tropicale). 
It is an acquired disease characterized by unknown etiology that is usually responsible for 
malabsorption, multiple nutritious deficiencies and alterations of small intestine mucosa. It is 
mainly common in Caribbean, in the south of India and in the south-east of Asia. The causes that 
are supposed to be responsible for the disease are bacterial, viral or parasitic infections, vitamins 
deficiencies and food toxins. 
 A rare disease, that is mainly common among men aging between 30 and 60 years old, is the 
Whipple's disease, provoked by the Tropheryma whippelii bacterium. The pathology is clinically 
characterized by anaemia, cutaneous pigmentation, articular symptoms, weight loss, diarrhea and 
heavy malabsorption. Small intestine mucosa is always damaged, as it is characterized by lesions 
observable during specific and diagnostic biopsies. 
 Intestinal lymphangiectasis is instead a syndrome characterized by a either congenital or acquired 
deformity of intramucous small intestine limphatic vessels. It affects mainly children and young 
adults. 
 Another pathology responsible for intestinal absorption deficiencies is the "short intestine" 
syndrome, which determines a typical inadequate absorption surface. It often results from either 
an extended intestinal resection or from jejenum-ileum bypass conceived as intervention against 
pathological obesity. An inadequate absorption surface causes consequently insufficient calories 
absorption and malabsorption of B12 and other vitamines, that can be responsible for acute poor 
nutrition with neurological deficiencies. 
This general outline describing both the causes, the consequences and the physiological 
implications of intestinal malabsorption, allows to understand the importance of a physio-
pathological in vitro model conceived as a useful tool to study the pathologies in terms of their 
dynamic development and characteristic features. This tool could allow also to develop and 
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optimize pharmacological focused effects 
1.2   STATE-OF-THE-ART RELATIVE TO INTESTINE MODELS: 
The model proposed is conceived as an in vitro tool, aimed at simulating the intestinal barrier, in 
terms of biological interface and of porous exchange and absorption path of drugs and solutes. The 
intestinal epithelium acts as a selectively permeable barrier, through the formation of complex 
protein-protein networks that mechanically link adjacent cells and seal the intercellular space. The 
protein networks connecting epithelial cells form three adhesive complexes: desmosomes, 
adherens junctions, and tight junctions.  These complexes consist of transmembrane proteins that 
interact extracellularly with adjacent cells and intracellularly with adaptor proteins that link to the 
cytoskeleton [46]. The predominant cell type in all absorbing regions is referred to as an enterocyte. 
Enterocytes are columnar epithelial cells that are bound to their neighboring cells at the luminal 
surface by tight junctions. Their apical cell membranes posses numerous microvilli which greatly 
increase the surface area available for absorption [47]. At various portions of the absorbing regions, 
absorption is favored by mucosal structures such as fenestrations (small holes) in the endothelial 
cells of the capillaries, or pores of different sizes in the membranes of the enterocytes. Underlying 
the lamina propria is a thin layer of smooth muscle, the muscolaris mucosae. In regions of active 
absorption such as the small intestine, the muscular layer appears to be related to the rhythmic  
movements of the villi that agitate the layer of intestinal secretions and chyme that are in contact 
with the epithelium and thus promote absorption. The co-ordinated, rhythmic contractions of these 
layers of smooth muscle cause the intestinal motility which is responsible for the thorough mixing 
of chyme, the continual rejuxtaposition of chyme with the brush border of the enterocytes, and the 
propulsion of food through the GI tract in a net aboral direction (peristalsis). The majority of the 
absorbing surface area is found in the jejenum. In particular the small intestine is characterized by 
an absolute surface area of about 111 m2 and the large intestine of about 0.19 m2. The value 
relative to the absorbing surface area affects directly the absorption rate of substances. Chyme 
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traverses the human small intestine at a rate of 1–4 cm per min. The velocity of transport is faster 
in the proximal portions of the small intestine (duodenum and proximal jejunum) and decreases as 
chyme approaches the ileum. On average, chyme traverses the entire small intestine in 3–4 h. 
Transit time for chyme in the human large intestine is considerably slower. This paragraph 
represents a review of the approaches documented in the state-of-the-art on this topic. The 
commonly accepted intestinal absorption model consists of a layer of Caco-2 cells (cells of the 
human colon), cultured on a polycarbonate membrane within a transwell [1,2, 10]. In this system, 
the compounds to be tested are added in correspondance to the apical side of the monolayer and 
the substances that pass through the cells are monitored in correspondance to the basolateral side. 
The traditional model poses some limitations, because the in vitro experiments are not able to 
reproduce many aspects of the in vivo behaviour. Cell cultures are characterized by substantial 
differences in comparison to the in vivo intestines phenotype, in terms of protein expression and 
cellular morphology. The limitation of the static monoculture is also related both to the use of a 
single cell type and to the lack of peristalsis, that reduces the overall permeability in comparison to 
the one measurable in vivo. The static condition represents a simplified model of the described 
physiological processes, which instead happen in a dynamic environment. The models proposed in 
the state-of-the-art, conceived as possible alternatives to the traditional one, belong to three main 
research fields [18]: 
SYNTHETIC-BIOLOGICAL MICROFABRICATED INTESTINE MODELS: 
The biomimetic models proposed tend to reproduce the in vivo microenvironment and they provide 
realistic in vitro models of intestinal villi, which are important to study and predict intestinal 
absorption. 
A first example is the model proposed by Wang et al. [19]. In this case, micromachining approaches 
were used to create a crypt-like microarchitecture, reproducing intestinal mucosa topography 
composed of crypts and villi onto polymeric substrates. Figure 1.13 depicts such structure. 
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Figure 1.13: Crypt-like structure microfabricated onto polymeric substrates: images of the structured mold, top view and 
section of the developed PDMS scaffolds. 
The superficial crypt-like topography guarantees a higher metabolic activity in comparison with a 
flat structure. This analysis was later reexamined, by adding a collagene type I membrane, properly 
designed and structured to study the synergy of the crypt-like structure and of the ECM proteins in 
terms of adhesion, proliferation and differentiation of intestinal Caco-2 cells and development of 
cell junctions [20]. The importance of the crypt-like structure was evaluated in terms of short-term 
effects on the cellular phenotype, regarding Caco-2 cellular differentiation and enzymatic activity. 
On the other hand, the substrate surface chemistry, related to the ECM proteins used for the 
coating, affects the long-run behaviour of intestinal epithelial cells. 
Gunawan et al [21] proposed a model in which they created protein gradients (laminin and collagen 
type I) similar to those found in the small intestinal crypts on an artificial substrate, by using 
microfluidic gradient generators. This study aimed at understanding the role of ECM proteins on the 
30 
 
intestinal epithelial renewal along the crypt-villus axis. Figure 1.14 depicts the model proposed. 
 
 
Figure 1.14: ECM proteins pattern of crypt-villus epithelium obtained by using microfluidic platforms. 
Another emerging approach to engineer biomimetic GI tract is based on the use of hydrogels. 
Hydrogels have attracted great attention for 3D cell cultures since they mimic the ECM and can be 
easily modified to generate tailored microenvironments [22-26]. Recently, Sung et al. developed a 
biomimetic GI tract model by using laser ablation combined with sacrificial molding in microscale 
collagen hydrogels mimicking the actual density and the size of the human intestinal villi ([27)]. 
Caco-2 cells seeded onto the structure covered the whole structure resembling finger-like intestinal 
villi covered with epithelial cells, figure 1.15. 
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Figure 1.15: SEM and fluorescence images of the structure composed of PDMS villi. 
In the paper [28] Shuler and his research group succeded in recreating the intestinal mucosa layer 
by the use of cellular lines representing intestinal epithelium, cells secreting mucine and lymphoid 
cells. The team realized a collagen structure representing the villi that cover intestinal epithelium 
and that allow absorption of drugs and substances. Finally another interesting work ([29]) was 
based on the fabrication of polymeric microporous membranes, either flat or containing 
controllable 3-dimensional shapes. Caco-2 cells were cultured onto the membranes to mimic key 
aspects of the intestinal epithelium such as intestinal villi and tight junctions (Figure 1.16). The 
developed membranes could be integrated with microfluidic, multi-organ cell culture systems, thus 
providing access to both sides, apical and basolateral, of the 3D epithelial cell culture. 
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Figure 1.16 :Images representing Caco-2 cell cultures on membranes characterized by silicon pillars. 
The papers proposed are characterized by the advantage of reproducing the morphological features 
of the in vivo environment (in particular the crypt-villus topography of the intestinal barrier), by the 
use of microfabrication techniques. They are models close to the physiological environment from 
the morphological point of view, but on the other hand this approach does not include the dynamic 
conditions that characterize the in vivo environment, such as fluid flow and peristalsis. These models 
are thus lacking of important factors that affect considerably the transit of substances through the 
intestinal barrier. 
2.     MICROFLUIDIC-BASED APPROACHES: 
The field of microfluidics is increasing its relevance for drug discovery, development and 
personalized biomolecular diagnostics. Due to the ability of microfluidic systems to provide fluid 
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flow in physiological ranges, it offers spatial and temporal fluidic control in a biomimetic 
environment enabling long-term cell culture and spatial differentiation. Thus, microfluidics is 
becoming an integral part of cell-based assays to predict oral drug absorption. For realistic 
prediction of oral drug bioavailability, an in vitro model should incorporate all the major 
physiological obstacles to the drugs entry into systemic circulation. These include the transport 
properties of the epithelium, liver metabolism, and the vascular transport that links them. At this 
proposal, to overcome the limitations of monoculture systems, transwell co-colture models have 
been designed to include apical Caco-2 monolayers along with hepatocytes in the basolateral 
compartment [30,31]. However, these models use large liquid to cells ratios and are devoid of 
circulatium of medium. To overcome these limitations, some solutions were proposed. To generate 
a biomimetic microenvironment for drug absorption studies, perfused co-culture systems based on 
microfluidics were designed. In the paper [32] Mahler et al for example co-cultured mucous 
secreting HT29-MTX goblet-like cells with Caco-2 cells to mimic intestinal cell populations and 
HepG2/C3A cell line as liver cell populations. Microfluidics has been also used to design a bioreactor 
system that allows to tune physiologically meaningful flow conditions in order to study various 
epithelial cell transport processes [33,34,35]. Ferrel et al [45] fabricated a bilayer microfluidic 
system with integrated transepithelial electrical resistance (TEER) measurement electrodes to 
evaluate kidney epithelial cells under physiologically relevant fluid flow conditions. The apical and 
basolateral fluidic chambers were connected via a transparent microporous membrane. The top 
chamber contained microfluidic channels to perfuse the apical surface of the cells whereas the 
bottom chamber acted as a reservoir for transport across cell layer and provided support for the 
membrane. TEER electrodes were integrated into the device, to monitor cell growth and evaluate 
cell-cell tight junctions integrity in real time. Such bioreactors can be easily integrated with perfused 
co-culture systems that closely mimic GI epithelial barriers along with first pass metabolism 
described above. Kimura et al. developed a microfluidic device embedded within a stirred-based 
micropump, to create on-chip perfusion, and an optical fiber connection for on-line fluorescence 
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detection for drug screening and toxicity tests ([36]). In another study [37], a microfluidic device 
containing microhole arrays was fabricated, as an example of a microfluidic system used to study 
intestinal absorption. The device is a microchip-based system that mimics the intestine. The 
microchip was composed of a glass slide, a permeable membrane, and polydimethylsiloxane 
(PDMS) sheets, which contained microchannels made by photolithography; Caco-2 cells were 
cultured on the membrane in the microchip. The system was regulated with a microsyringe pump, 
that was able to generate slow pulsatile fluid flux. In particular, PDMS microchips are composed of 
two layers; each of them is endowed with microfabricated channels (apical and basolateral side) 
and with channels connecting the upper and the lower parts. The interface between the upper and 
the lower chambers is a BioCoat membrane, working as a scaffold that allows Caco-2 cells culture 
and growth. The microchip has two microchannels separated by a Caco-2 cells monolayer cultured 
on a porous membrane. These devices were used to perform permeability tests. The passage of two 
different substances characterized by a different ability to permeate through the intestinal barrier 
was assessed. The mixture containing the compound to be tested was added on the apical side, 
whereas the basolateral side contained the control fluid, representing the baseline.The final 
purpose of the work was to perform transport and absorption studies of substances and drugs 
through the intestinal barrier. This could be a useful tool for drugs screening in order to estimate 
their bioactivity.  These models are able to mimic the dynamic conditions of the physiological 
environment and include cellular co-cultures that allow to overcome the limitations of the 
traditional monoculture model. On the other hand, these models are not able to mimic intestinal 
peristalsis, which is an important factor promoting the processes of transport of nutritious 
substances and drugs through the intestinal barrier. 
3 MICROSCALE CELL CULTURE ANALOGS (μCCA):  
This approach considers that drug absorption, distribution, metabolism and excretion is a result of 
the interactions between various cells, tissues and organs that are interconnected by vasculature. 
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In the state-of-the-art there are many physiologically-based pharmacokinetic models (PBPK), which 
describe an organism as a set of interconnected tissue or organ compartments based on 
vasculature. Their main purpose is to calculate the time-dependent distribution of a drug in various 
tissues [38]. An important advancement in the field of drug screening is the integration of multiple 
miniaturized organ model systems into a single device to recapitulate the potential interaction 
between different organs. The concept of "microscale cell culture analogs" is a physical 
representation of PBPK model where different cell types are cultured in small chambers 
interconnected by fluidic channels [39]. Such systems offer versatile in vitro models to study drug's 
biotransformation, and interaction between different tissues in determining drug's response (both 
efficacy and toxicity). The paper [40] is an interesting review that supplies an overview of the various 
approaches, provided in the state-of-the-art aimed at evaluating intestinal permeability and 
predicting pharmaceutical properties of biocompounds. An initial approach is based on the 
realization of in vitro models; their advantage is that they give the possibility to quantify the 
transport of substances through a cellular barrier. The main limitation of these methods is that they 
do not allow to quantify the amount of active drug transport observable in vivo. The review 
describes various methods proposed as alternatives to in vitro physio-pathological models. In 
particular, screening methods of membranes permeability are documented in literature as valuable 
alternatives to cell cultures. An example is the artificial phospholipidic membrane (paper [41]), 
obtained by soaking with phospholipids and with an organic solvent 96-well microtiter filter plates. 
The system allows to study the passive transmembrane transport, that is the main route of transport 
of drugs and other substances through the intestinal barrier. Recently, chromatographic methods 
aimed at modeling drugs intestinal permeability, have been studied. They allow to evaluate drugs 
interactions and/or their distribution in the membrane lipids, rather than quantifying the transport 
through them. In the state-of-the-art, some theoretical models of the intestinal permeability were 
introduced; they represent valuable alternatives to the wide spectrum of in vitro and in silico 
models. Theoretical models allow to estimate intestinal permeability and they are based on the 
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most meaningful parameters that describe the subject matter of the research. In particular, the 
models contemplate the calculation of lipophilicity, hydrogen bonding and molecular dimensions 
[42,43]. These computational approaches, aimed at predicting the transport through the 
membrane, allow the prediction of passive transcellular transport and subsequently the 
development of a theoretical reference model. The ability of a molecule to permeate a cell depends 
on the number and the strength of the hydrogen bonds that the molecule forms with water. Drug 
lipophilicity instead is a predictor of membrane permeability, since it is assumed that drug 
partitioning into the (lipophilic) cell membranes is a rate-determining process for passive membrane 
permeation. The process of partitioning within the membrane is a two-step process led by two 
decisive forces for the permeability rate through the membrane: lipophilicity and hydrogen bonds 
forming potentiality. The theoretical models take into accout other predictors of passive transport 
through the membrane, such as: solute size, molecular surface properties (they depend on drug 
molecules shape and on their steric hindrance) and Polar Surface Area (PSA). PSA is defined as that 
part of molecular surface area contributed by nitrogen and oxygen atoms, plus the area of the 
hydrogen atoms attached to their heteroatoms. Many studies demonstrate the correlation between 
"non polar surface area" and intestinal permeability. Approaches based on quantum mechanics 
calculations have recently been used to predict passive membrane permeability to drugs and other 
compounds. Norinder et al. developed a method for predicting Caco-2 cell monolayer permeability 
to a series of structurally diverse conventional drugs. They used molecular mechanics methods and 
the global minimum conformation, that was then subjected to a further semi-empirical structural 
optimization. These approaches,that were quoted to obtain a complete overview, take into account 
physical properties and electronic effects (for example charge distribution) to build up theoretical 
prognostic models of membrane permeability based on proper parameters. 
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1.3  OVERVIEW OF LOCs (Lab On Chip Technologies) AND CURRENT DRUG 
TESTING SYSTEMS: 
 
LOC (Lab On Chip) technologies aim at developing biomimetic in vitro models. These models tend 
to reproduce the main functional properties of various organs and tissues and consequently to 
simulate various physiological and pathological conditions. The purpose is to preliminarly study 
physiological phenomena and to predict the in vivo behaviour and metabolism. Cell chips allow 
elegant and systematic design of various physiological factors such as extracellular matrix, cell-to-
cell communications, molecular concentration gradients. In the state of the art various organ-
mimetic microdevices with integrated functionalities were proposed. They reproduce key structural, 
functional, biochemical and mechanical features of living organs.  They offer a tool in vitro aimed at 
simulating important processes characteristic of particular diseases and strictly dependent on 3D 
organ architecture. Other systems that envisage 3D cell cultures have been also developed. They 
overcome the limitations of bidimensional models and they try to compensate their deficiencies in 
reproducing the microenvironment in vivo. "Organs on chip" integrate microfluidic technologies and 
living cells cultured in 3D microfabricated devices, to study human phisiology in a context organ-
specific, to develop in vitro models of specific pathologies and to create 3D models able to replicate 
more complex structures at organ or biological interface level. 
Miniaturized cell chips [3] are characterized by the following main advantages in respect to the 
limitations characterizing the traditional tools: 
• reduction of cell/drug consumption (important for rare cell analysis and cost reduction) ; 
• high surface area-to-volume (SAV) ratio, that facilitates heat transfer to achieve precise 
temperature control for healthy cell culture; 
• laminar fluid flow and diffusion-dominated mass transport process, to well resemble the in 
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vivo condition; 
• Integration of different functional units for cell-drug reaction, cell sorting and cell response 
detection to allow serial processing and analysis of various cell/drug samples; 
• massive parallelization of miniaturized functional units to achieve high throughput and 
multi-parametric analysis of drug induced cellular responses; 
• more accurate control of the cellular microenvironment and a decrease of the biological 
variability between different cells and cultures; 
• major predictive potentiality of the response and consequently economic advantages in 
drug testing experiments; 
• possibility to manage with miniaturized devices that are characterized by low 
manufacturing cost. 
In general, on-chip technologies include two categories: 
• MICROFLUIDIC CELL CHIPS: they are tipically composed of microchannels with several 
functional units such as micropumps and microvalves to transport drug compounds to 
target cells. 
• NON-FLUIDIC CELL CHIPS: they usually consist of solid supports where small volumes of cells 
can be displayed in defined locations, allowing multiplexed interrogation and analysis of 
living cells (microwell cell chips, micropatterned cell arrays etc). 
As most part of drugs screening methods involve the cellular expression of recombinant targets and 
subsequently  the study of cell-drug interactions by rapid and quantifiable assays, the merits of a 
cell chip make it an ideal tool to investigate cell-drug interactions. Since the model proposed in this 
work envisages a possible future application in drug testing systems, subsequently an overview 
about the main systems developed so far is proposed in order to contextualize the matter. Recently 
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novel microfabrication technologies were developed; they allow to interface the cells with drug 
testing systems. They are integrated systems that include cell cultures and engineered tools 
designed ad hoc for the specific application. The paper [14] aimed at engineering cellular 
microenvironments to improve cell-based drug testing and systemic toxicity studies. 
 Another example of this type of systems is the paper [15]. It proposes a drug-screening in vitro  
platform for drug screening based on the contractility of tissue-engineered muscle. A tissue-based 
approach to in vitro drug screening allows for determination of the cumulative positive and negative 
effects of a drug at the tissue rather than the cellular or subcellular level. Skeletal muscle myoblasts 
were tissue-engineered in three-dimensional muscle with parallel myofibers generating directed 
forces. The miniature bioartificial muscles were able to generate tetanic (active) forces upon 
electrical stimulation measured with a novel image-based motion detection system. The tool 
proposed is a system that allows to evaluate tissue or organ-specific effects caused by different 
compounds. The results described in the paper demonstrate the integration of tissue engineering 
and biomechanical testing into a single platform for the screening of compounds affecting muscle 
strength. In particular the authors analyzed the muscle response to compounds that increase or 
decrease muscolar hypertrophia and contractile strength. The muscolar force in  response to 
different types of drugs was measured. In particular, changes of muscolar contraction are 
symptomatic and representative of the general effects induced by a compound at the expense of 
all of the biochemical mechanisms that are involved in the process of force generation. 
Some other meaningful studies belonging to this research domain are described below. Ingber et 
al. designed  and realized a lung-on-chip device ([4]). This biomimetic microsystem reconstitutes 
the critical functional alveolar-capillary interface of the human lung. This bioinspired microdevice 
reproduces key functional, structural and mechanical properties of the alveolar-capillary interface, 
that is the fundamental unit of the living lung. This was accomplished by microfabricating a 
microfluidic system containing two closely apposed microchannels separated by a thin (10 µm), 
40 
 
porous, flexible membrane made of poly (dimethylsiloxane) PDMS. The intervening membrane was 
coated with ECM (fibronectin or collagen), and human alveolar epithelial cells and human 
pulmonary microvascular endothelial cells were cultured on opposite sides of the membrane. Once 
the cells were grown to confluence, air was introduced into the epithelial compartment to create 
an air-liquid interface and more precisely mimic the lining of the alveolar air space. The system 
involves two lateral microchambers. When vacuum is applied to these chambers, it produces elastic 
deformation of the thin wall that separates the cell-containing microchannels from the side 
channels; this causes stretching of the attached PDMS membrane and the adherent tissue layers. 
This design replicates dynamic mechanical distortion of the alveolar-capillary interface caused by 
breathing movements: that is the mechanical forces acting on the cells when the individual's thorax 
expands and contracts. Figure 1.17 depicts the structure of the described model. 
 
 
Figure 1.17: Structure of the lung-on-chip bioinspired microdevice. 
The study demonstrated that epithelial cells were able to reproduce the permeability of the barrier 
within the microsystem and that their behaviour changed when they are stretched. The system was 
conceived for direct and quantitative evaluation of various biological processes of the human lung 
and it overcame the limitations of both animal and of traditional cell cultures models. The device 
allowed the application of cyclic stretching and fluid shear stress to two opposing cells layers 
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separated by a permeable and flexible ECM, while simultaneously enabling analysis of tissue barrier 
permeability and transport. The microsystem on-chip proposed in the paper was also validated in 
the case of the simulation of more complex integrated organ-level responses, observed in whole 
living lung, such as pulmonary inflammation, by incorporating blood-borne immune cells in the fluid 
flowing through the vascular channel. The bioinspired microdevice was evaluated also for 
nanotoxicology studies, thanks to the pulmonar response to nanoparticles released in 
correspondence of the epithelial compartment. The authors demonstrated that cyclic mechanical 
strain accentuates toxic and inflammatory responses of the lung to silica nanoparticles. The 
importance of the model proposed consists of the combination of a biohybrid tool simulating a 
tissue-tissue interface and of an actuation system replicating the breathing movements of the 
organ. The final purpose is obtaining a biomimetic device as more plausible as possible, in respect 
to the in vivo behaviour. The proof-of-concept of this research work is similar to the model proposed 
in Ingber's paper. The basic idea is infact engineering an interface between epithelial and muscolar 
tissues, in order to reproduce the intestinal barrier in terms of both permeability and peristalsis. 
The model proposed infact can be actuated in order to reproduce the peristaltic movements of 
intestines in vivo. Peristalsis infact represents a key feature both in terms of metabolic and of 
transport processes. 
Another example of "organ-on-chip" is the system "artery-on-chip" ([5]). It consists of a device 
designed to study "resistance arteries". They are blood vessels characterized by small diameters, 
that contribute to the regulation of the blood flow lead into the capillaries lumen, to prevent their 
damage. The blood vessel was at first removed from a mouse and it was then sutured at the 
extremities. Both inside and outside the vessel the in vivo physiological pressure was replicated. The 
device allows the researchers to insert a blood vessel within a microfluidic chip. A chamber designed 
ad hoc allows to maintain the blood vessel in a defined desired location, supplies liquid continuosly 
through it and allows to analyze a set of drug doses and different timing, by the use of a computer 
controlled system. 
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Another important system documented in literature ([7]) is aimed at replicating bone structure by 
the use of an array of PDMS microchambers interconnected by narrow (1µm wide) channels. The 
device was similarly used to enable growth and in vivo-like reorganization of osteocytes in a 
structured 3D environment. Other examples include a compartmentalized microfluidic system [6] 
that enables co-culture of neurons and oligodendrocytes to study neuron-glia communication 
during development of central nervous system and a microdevice [8] incorporating ECM gels 
microinjected between two parallel microchannels to investigate the vascularization of liver tissues 
in 3D culture microenvironments. The paper [9] describes an example of tissue engineering as a 
promising approach for esophageal replacement, to reconstruct in vitro esophageal walls. The 
researchers analyzed the feasibility and the optimal conditions of human and pig skeletal myoblasts 
(HSM and PSM) and porcine oral epithelial cells (OEC) culture on biologic scaffolds. Myoblasts 
proved to be able to differentiate and to promote the renewal of damaged muscolar fibers. 
Epithelial cells accelerate the process of muscle renewal and prevent the stenosis subsequent to 
circumferential esophageal replacement. The paper highlights the importance of the use of co-
cultures in tissue engineering; the approach proposed is hybrid and it combines matrixes and 
cellular co-cultures. 
This research field involves also the development of in vitro physio-pathological models of particular 
diseases. An example is a device fabricated by the use of two layers of PDMS micro channels, stacked 
and separated by a thin porous membrane. The device is used to create eterothipic multicellular 
spheroids in a 3D microfluidic culture system, that reproduces the cancerous microenvironment of 
prostate metastatic cells [44]. 
A further development of this research field is aimed at the development of multi-micro organoid 
chips. These chips are in vitro models that do not represent a single organ on its own, but they 
simulate the crosstalk and the interactions among various organs. This analysis is important in the 
context of systemic toxicity studies. This researc field is aimed at the development of models 
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composed of interconnected compartments, each one of them representing a distinct organ. The 
various constituent organs are interconnected by a microfluidic circulatory system. In the state-of-
the-art, there are several interesting examples. Some of them are based on silicon wafers "etching", 
to obtain little compartments that could include intestinal, epathic and adipose tissue cells, 
interconnected by microfluidic channels. The paper [11] proposes another alternative solution for 
drug testing to predict human exposure, by the use of "human multi-micro-organ" systems 
composed of miniaturized bioreactors. The authors designed and simulated a system that envisages 
long-term dynamic on chip cultures of the smallest functional units of human organs, called "micro-
organoids". Every chip contains six identical micro bioreactors. Each bioreactor contains three 
different micro-organoids culture segments, a nutritious substances supply and a reservoir. In 
particular micro-organoids segments of liver, cerebral cortex and bone marrox were cultured within 
each bioreactor. The platform of the device is dedicated to maintain human micro-organoids of liver, 
bone marrow and cerebral cortex within a systemic and controlled micro environment. The recent 
advance in range of Lab On Chip Technologies are "human-on-chip" systems, that represent an 
interesting future perspective. This research field concerns the development of 3D models aimed 
at simulating the metabolism and the physiology of the whole organism by the use of a system 
composed of compartments interconnected by a vascular network. In the paper [12] Esch et al. 
proposed an example of "human-on-chip" system. It consists of a microfabricated bioreactor 
containing 2D cultures of hepatic and pulmonary cells within distinct micro chambers, connected 
by microfluidic channels. The system was later modified with the addition of either 2D or 3D cultures 
of fat cells, cancer cells and marrow stem cells. It is aimed to appreciate systemic drug accumulation, 
distribution and absorption. 
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1.4  MODEL PROPOSED: 
 
The device proposed in this Thesis is a biomimetic tool aimed at simulating the intestinal barrier, 
both as an interface that allows substances transport and drug absorption and as an engineered 
biohybrid actuator that reproduces intestinal peristalsis. The intestinal peristalsis is in fact an 
important factor that promotes the transit of bio-compounds in the GI tract and the transport and 
absorption of drugs and solutes through the intestinal barrier. The model mimics the intestinal 
barrier as permeable selective interface by the use of an engineered porous PLA nano-membrane. 
On the opposite sides of the membranes Caco-2, cells of intestinal epithelium and contractile 
cardiac muscle cells were cultured. Muscle stretch the supporting membrane and subsequently 
actuate the overall device, thanks to their capacity to develop active contractile force. Theoretically 
it should be necessary to use smooth muscle cells, to obtain a more plausible model of the 
anatomical structure of intestinal barrier in vivo. However, their contraction has to be induced by 
external electrical stimuli, so in this case it would be indispensible to integrate bioelectrodes in the 
system. The problem was splitted in multiple levels of difficulty, because the initial purpose was 
really ambitious. In this initial prototype the problems due to external electrical stimuli to contract 
the muscolar fibers and due to the integration of bioelectrodes in the system were neglected and 
removed. Smooth muscle cells were thus replaced with cardiomyocites, characterized by 
spontaneous contraction and not needing external stimuli. 
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2.  MATERIALS AND METHODS 
 
2.1  DEVELOPMENT OF POROUS NANOFILMS 
 
In the firts phase of the Thesis, different fabrication techniques aimed at developing porous 
nanofilms were evaluated. The first attempt was based on spin coating deposition of a dispersant 
poly (lactic-co-glycolic)acid (PLGA polymeric solution) containing a disperse phase of a porogen 
(water-soluble)  particulate. Salt leaching was then performed in deionized water. The second 
approach relied on a fabrication technique, based on soft lithography. This last procedure aimed at 
developing a micro-patterned mold to be exploited for achieving a porous nanofilm with a highly 
controllable structure. 
 
2.1.1  Microfabrication technique based on spin coating and salt leaching 
 
The salt leaching technique is one of the most common microfabrication methods used to develop 
porous scaffolds. The procedure is based on a mixture of a dispersant solution, insoluble in water, 
containing particles of a water-soluble porogen in suspension. When the mixture is immersed in 
water, the porogen is dissolved and subsequently determines the presence of pores in the resulting 
scaffold. The microfabrication technique investigated in this Thesis is based on spin coating 
deposition of a PLGA thin polymeric film containing water-soluble porogen particles and further salt 
leaching in deionized water. The analysis included the comparison between two different porogens, 
namely glucose and sodium chloride, a set of concentrations of the PLGA polymeric solution and 
different spinning speeds. 
 
Poly (lactic-co-glycolic) acid (PLGA) 
PLGA is a copolymer which is widely used to develop therapeutic devices, thanks to its 
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biodegradability and biocompatibility. PLGA is synthesized by means of random ring-opening co-
polymerization of two different monomers, glycolic acid and lactic acid. It is characterized by the 
molecular formula shown in Figure 2.1: 
 
 
Figure 2.1: PLGA molecular formula. 
 
PLGA degrades by hydrolysis of its ester linkages in the presence of water. The time required for 
degradation of PLGA is related to the monomers'ratio used in production: the higher the content of 
glycolide units, the lower the time required for degradation. PLGA has been successful as a 
biodegradable polymer because it undergoes hydrolysis in the body to produce the original 
monomers, lactic acid and glycolic acid. These two monomers, under normal physiological 
conditions, are by-products of various metabolic pathways in the body. Since the body effectively 
deals with the two monomers, there is minimal systemic toxicity associated with using PLGA for 
drug delivery or biomaterial applications. Even if PLGA is a biodegradable polymer, the time 
duration required for its degradation is rather long and it results thus negligible for our purposes. 
PLGA characteristics which guarantee its massive use are both its high biocompatibility and the 
possibility to use the polymer efficiently in order to obtain thin films. 
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Polyvinyl Alcohol (PVA): 
 
 
Figure 2.2: PVA molecular formula. 
 
PVA is a water-soluble synthetic polymer, which is odourless, colorless and insoluble in organic 
solvents. Thanks to these properties PVA can be used as an efficient water-soluble sacrificial layer. 
PVA has an excellent capability to form films. In this Thesis, PVA was used to develop water-soluble 
sacrificial layers.  
 
 
 
Spin Coating 
 
 
Spin coating is a common micro/nano fabrication procedure used to deposit uniform thin films onto 
flat substrates. Usually a small amount of coating material is applied on the center of the substrate. 
The substrate is then rotated at high speed in order to spread the coating material by centifugal 
force. The film final thickness is the result of the combination of two determining parameters: spin 
coating procedure duration and spin speed. Higher spin speeds and longer time duration allow to 
attain thinner substrates. After high-speed spin coating, the sample is heat-treated; this phase 
allows to dry the sample, without further reducing its thickness. This step is fundamental to 
guarantee the physical stability of the sample and to consequently avoid further problems of film 
handling. Acceleration is another crucial parameter. In fact, in many processes, half of the solvent 
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tends to completely evaporate during the initial seconds. Furthermore, acceleration affects also 
coating properties of patterned substrates. In fact, while the spinning process is responsible for the 
radial outwards force, the acceleration determines on the material a twisting rotational force. The 
twisting force contributes to the dispersion of the material on the entire surface of the substrate 
[54]. The spin coater used is WS-650 spin processor model, Laurell Technologies Corp., North Wales, 
PA. All the routines for PLA nanosheets fabrication were conducted in a clean-room (class 1000) to 
avoid contamination. 
 
 
 
 
Experimental procedure 
Porogen preparation and characterization 
 
The porogens (glucose and sodium chloride, both puchased from Sigma Aldrich) were at firts 
grinded in a ceramic mortar and later sifted, in order to control the maximum size of porogen 
grains. The analysis included different time durations of the pounding phase: 5, 10, 15 and 20 
minutes, respectively. The sifting phase instead consisted of two serial steps, based on the use of 
sieves having knit size of 63 μm and 38 μm. The choice allowed to control the porogen grain 
dimensions and to set a maximum admissible size. Grain dimensions were quantified by means of 
SEM analysis of the porogen particles, previously dissolved in dichloromethane and, after the 
complete evaporation of the solvent, gold sputtered and imaged.  
 
Fabrication of porous PLGA nanofilms by means of spin coating and salt leaching 
Silicon wafers (Si-Mat Silicon Materials, Kaufering, Germany) were used as substrates for the 
spinning technique. The silicon wafers were cut in 2*2 cm pieces, then cleaned with acetone and 
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isopropyl alcohol, throughly rinsed by deionised water, to ensure acetone removal and finally dried 
by an air flux.  
A solution of PLGA in chloroform was mixed with the two porogens (glucose and sodium chloride). 
Two different PLGA concentrations and a set of porogen fractions, suspended within the PLGA 
solution, were tested and compared. Table 2.1 resumes the cases analyzed: 
 
PLGA concentrations [mg/ml] 
 
Glucose concentrations [mg/ml] Sodium chloride concentrations 
                  [mg/ml] 
100 100 5 
50 10 1 
 5 0,5 
 1  
Table 2.1: Schematization of the different concentrations of both the dispersant and the two disperse phases analyzed. 
 
A PVA (Mw 13000-23000, 98% hydrolyzed) aqueous solution (1% w/ v) was deposed by spin-coating 
on a silicon wafer (at 4000 rpm for 20 s) forming the water-soluble sacrificial layer, promoting film 
detachment from the wafer itself. 
Then the emulsion, composed of PLGA and porogen, was spin-coated on the first layer, by 
maintaining the same spinning parameters (3000 rpm, 20 s) in all the cases. After drying the samples 
(at 80 °C for 1 min), they were immersed in deionized water in order to dissolve both the sacrificial 
layer and the porogen particles. As a consequence, the PLGA nanofilm was released free-standing 
in liquid and the porogen was leached out in water. The resulting nanofilms were finally analyzed by 
SEM imaging. 
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2.1.2  MICROFABRICATION TECHNIQUE BASED ON PHOTOLITHOGRAPHY 
Development of patterned molds 
Lithography refers to a family of micro/nano fabrication techniques used to pattern parts of a thin 
film or the bulk of a substrate, useful to develop or to replicate microstructures. These techniques 
allow to develop patterned molds having a well-defined topography, by the use of a photomask 
designed ad hoc as a function of the desired prototype. The photomask consists of a glass substrate 
with a thin chrome layer on its surface, characterized by a precise pattern. Chrome is not transparent 
to UV light; this property guarantees the possibility to expose to UV light precise areas through the 
mask, not covered by the opaque chrome layer [55]. Photolithography uses light to transfer a 
geometric pattern from a photomask to a light-sensitive chemical “photoresist”, on the substrate. 
The photoresist that are sensitive towards UV light can be either positive or negative, according to 
the reaction activated by the interaction between the UV rays and the material. Positive 
photoresists, after UV exposure, start to reticulate, whereas negative photoresists do not reticulate 
during post-bake phase subsequent to UV exposure. In particular, positive photoresists after UV 
exposure become more soluble in the developer solution, allowing the removal of the exposed 
areas. UV exposure infact modifies the chemical structure and the properties of the material, and 
particularly its solubility in the developer solution. The post exposure rinsing in the developer 
solution allows to replicate on the wafer a pattern mold, that is the exact replica of the photomask. 
Negative photoresists behave in an opposite way. In this case in fact, after UV exposure, the resist 
polymerizes and becomes consequently less soluble in the developer solution. The negative resist, 
after UV exposure is not removed by the developer solution, but remains on the surface. In this case 
the areas that are removed are in fact those not directly exposed to UV light. In the case of negative 
photoresists, the photomask is characterized by the inverse pattern in respect to the structure that 
has to be impressed on the silicon substrate [56].  
 A photomask was designed ad hoc by means of Autocad, in order to obtain patterned molds 
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characterized by a well-defined topography. The photomask was provided with cylindrical 
pillars having diameters of about 5 μm and mutual distances between adjacent pillars of 5 
μm. This choice would allow to obtain as a final result nanofilms having theoretically an 
average porosity of about 20%. 
 Silicon wafers were cleaned at first with acetone and isopropyl alcohol, thoroughly rinsed 
by deionised water and dried. The chemical treatment of the silicon wafers aimed at 
removing organic or inorganic contaminations that are present on the surface. Cleaned 
wafers were finally dehydrated by means of thermal treatment at 120 °C for 30 minutes, to 
drive off any moisture that may be present on the wafer surface. 
 A MICROPOSIT PRIMER solution was deposed by spin-coating on a silicon wafer, by using 
constant spinning parameters [3500 rpm, 30 s], to promote adhesion of the photoresist to 
the wafer. 
 A positive photoresist SHIPLEY S1813 was deposed by spin-coating on the first layer. The set 
of photoresist spin coating speeds that were tested is listed in Table 2.2: 
Photoresist spinning speed [rpm] 
1500 
2000 
2500 
3000 
Table 2.2: photoresist spin coating speeds. 
The time duration of the photoresist spin-coating phase was instead maintained constant 
and in particular equal to 35 s. 
 After photoresist spin coating deposition, the samples were baked at 120 °C for 1 min, to 
drive off excess photoresist solvent. 
 The wafers, previously coated with S1813 positive photoresist, were later exposed for 0.5 s 
to UV light by the use of a Mask Aligner in hard contact operating mode. UV exposure allows 
to imprint on the silicon wafer the desired pattern, causing a chemical change that allows 
some of the photoresist to be removed by the developer solution.  
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 The samples were immersed in AZ DEVELOPER solution for 1 s to selectively dissolve the 
exposed photoresist areas. 
 The developed samples were later rinsed by deionized water and dried with compressed 
air. 
 They were finally post-baked by means of a thermal treatment at 120 °C for 1 min. 
 
 
Development of porous nanofilms: 
Porous nanofilms were developed thanks to spin-coating deposition on patterned molds of a PLA 
polymeric film, on a firts layer of PVA water-soluble sacrificial layer.   
 
Polylactide acid (PLA): 
 
The compound used for nanofilm fabrication was PLA, purchased from Sigma-Aldrich (cod= 94829 
Mw= 67000 Mn=50000). PLA is characterized by the molecular formula shown in Figure 2.3: 
 
Figure 2.3: PLA molecular formula. 
PLA, a lactic acid polymer, is a thermoplastic aliphatic polyester. Due to the chiral nature of lactid 
acid, two distinct enantiomeric forms of polylactide exist: L and D. PLLA is the product resulting 
from polymerization of L, L-lactide. PLLA has a cristallinity of around 37%, a glass transition 
temperature between 60-65°C, a melting temperature ranging between 173 °C and 178 °C and a 
tensile modulus between 2.7-16 GPa [57]. PLA is able to degrade into lactic acid. Lactic acid is a 
compound at all innocuous in the biological environment. Lactic acid biocompatibility is a key factor 
that allowed us to select it for nanofilm fabrication, despite its degradability (anyhow, PLA 
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degradation rates are rather slow: it normally degrades in more than one year). 
In this Thesis, PLA (2% w/v in dichloromethane) was used to fabricate porous micro-/nano- films 
characterized by controlled thickness and porosity. 
 
Dicholoromethane 
 
 
Dichloromethane (or methylene chloride, DCM) is an organic alkyl halide compound that is widely 
used as a solvent. Although it is not soluble in water, it is miscible with many organic solvents. The 
molecular structure of the compound is shown in Figure 2.4: 
 
 
 
Figure 2.4: Dichloromethane molecular formula. 
 
 
At room temperature dichloromethane is a colorless, volatile liquid with a moderately sweet aroma. 
DCM is considered noxious and potentially carcinogenic, even if less than other solvents such as 
chloroform. DCM's volatility and ability to dissolve a wide range of organic compounds makes it a 
useful solvent for many chemical processes. 
 
Fabrication of porous nanofilms by means of spin coating on patterned molds 
 
At first a PVA aqueous solution (1% w/v) was first deposed by spin-coating (4000 rpm, 20 s) on 
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a patterned mold, previously  gold-sputtered (25 mA, 60 seconds) and plasma-treated . 
Thanks to the inert gold coating, gold sputtering prevented the PLA solution from chemically 
reacting with the underlying photoresist layer. Plasma treatment instead enhanced the 
hydrophile of the patterned mold and consequently increased the adhesion of PVA. The 
plasma treatment, achieved by using Colibrì plasma reactor purchased from Gambetti, was 
characterized by the following parameters: 
• Plasma Time: 90 s 
•  Power Set Point: 30 W. 
• Gas stb time: 0 s. 
• Oxygen setpoint : 50%. 
As mentioned, PVA formed the sacrificial layer. A following solution of poly (lactic acid) in 
dichloromethane (PLA 2% w/v ) was then spin-coated on the first layer by using the spinning 
parameters listed in Table 2.3: 
 
 
 
PLA Spinning Parameters 
3000 rpm, 20 s 
4000 rpm, 20 s 
5000 rpm, 20 s 
6000 rpm, 20 s 
7000 rpm, 20 s 
Table 2.3: PLA spin coating parameters                        
After drying the sample (80 °C; 1 min), the PVA sacrificial layer was dissolved in water thus 
releasing the PLA nanofilm free-standing in liquid. 
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2.2  SAMPLE CHARACTERIZATION: 
     
2.2.1  ATOMIC FORCE MICROSCOPE (AFM) 
 
 
Atomic Force Microscope AFM is a very high-resolution type of scanning probe microscope (SPM), 
which demonstrated resolution on the order of fractions of a nanometer and allows to attain an 
image at the atomic level of the scanned surfaces. AFM consists of a cantilever with a sharp tip 
(probe) at its end that is used to scan the specimen surface. The two main components of AFM are 
the probe and the scanner. The tip, which scans the various areas of the sample, is the interface 
between SPM and the sample itself. The scanner, instead, controls with high precision the position 
of the probe in respect to the surface, both horizontally and laterally. As the tip is brought very close 
to the surface of the object under investigation, the Van der Waals forces acting between the tip 
and the sample lead to a deflection of the cantilever according to Hooke's law, which is the what 
the AFM is designed to measure. A spatial map of the interaction can be made by measuring the 
deflection at many points of a 2D surface. Cantilever deflection is measured using a laser spot 
reflected from the top surface of the cantilever into an array of photodiodes. Figure 2.5 shows this 
operating principle: 
  
 
 
Figure 2.5: AFM operating principle. 
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The AFM can be operated in a number of modes, depending on the specific application. In general, 
the possible imaging modes can be divided into static and (also called contact) modes and a variety 
of dynamic (non contact or tapping) modes where the cantilever is vibrated. AFM operation is 
usually described as one of three modes, depending on the nature of the tip motion: 
Contact mode (STATIC MODE): the tip is 'dragged' across the surface of the sample and the contours 
of the surface are measured either using the deflection of the cantilever directly or, more commonly, 
using the feedback signal required to keep the cantilever at a constant position. 
Tapping mode: In the tapping mode the cantilever is driven to oscillate up and down at near its 
resonance frequency by a small piezoelectric element mounted in the AFM tip holder similar to non-
contact mode. The amplitude of the oscillation is modified by the interaction forces between the 
tip and the sample surface. Van der Waals forces, dipole-dipole interactions, electrostatic forces are 
responsible for the amplitude of this oscillation to decrease as the tip gets closer to the sample. An 
electronic servo controls the height of the cantilever above the sample by using the piezoelectric 
actuator. The servo adjusts the height, in order to maintain a set cantilever oscillation amplitude as 
the cantilever is scanned over the sample. A tapping AFM image is therefore produced by imaging 
the force of the intermittent contacts of the tip with the sample surface. The variations of the 
oscillation in relation to the external reference oscillation give information about the superficial 
features of the sample scanned. 
Non contact mode In this model the tip of the cantilever does not contact the sample surface. The 
cantilever is instead oscillated at either its resonant frequency (frequency modulation) or just above 
(amplitude modulation) where the amplitude of oscillation ranges typically from a few nanometers 
to a few picometers. The Van der Waals forces, which are the strongest from 1 nm to 10 nm above 
the surface, or any other long-range force that extends above the surface act to decrease the 
resonant frequency of the cantilever. This decrease in resonant frequency combined with the 
feedback loop system maintains a constant oscillation amplitude or frequency by adjusting the 
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average tip-to-sample distance. Measuring the tip-to-sample distance at each data points allows the 
scanning software to construct a topographic image of the sample surface. 
The AFM used in this Thesis is Veeco Innova Scanning Probe Microscope. The samples, having 
dimensions of 1 cm*1cm, were at first positioned on a proper supporting metal small disc. The 
software used to control by computer the AFM probe and to set the proper scanning parameters is 
SPMLAB 7.20. By means of the ‘Motor Stage’ function provided by the software, the tip was raised, 
before positioning the sample on the proper location, in order to guarantee a sufficient tip-sample 
distance and to thus prevent from either breaking or damaging the tip itself. After the sample 
positioning in the proper location, by the use of the ‘Motor Stage’ SPMLAB 7.20 function, the tip 
was brought closer to the sample surface. Before starting sample scanning it is fundamental to 
guarantee both a proper detector alignement and a suitable cantilever resonant frequency.  
The parameters used to set the cantilever resonant frequency were: 
◦ Range: 0-1000KHz 
◦ Drive Amplitude:  1 V 
◦ Input Gai: x4 
◦ Target tapping signal: 7 V 
         Finally, AFM tip was engaged to the sample surface and the following scanning control 
parameters were set: 
• Samples/ line: either 256 or 512, in the case of high-resolution images. 
• Scan rate: 0.3 Hz 
• Scan range: 50.00 µm 
• Rotation: 0 
SPMLAB 7.20 software is furthermore endowed with a proper tool conceived for image analysis, 
which allows to analyze and elaborate the images of the scanned sample. Some of the 
functionalities offered by the image analysis tool are i.e. ‘Leveling’, which allows to choose the 
points of the image that lie on the same plane, ‘3D Display’ which performs a tridimensional map 
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of the sample topography, ‘Line Measure’ which allows to measure different characteristic features 
of the sample surface. Image analysis allowed to infer various and important information about 
sample qualitative and quantitative features.  
Both patterned mold topography and nanofilm thickness were characterized by means of AFM 
scanning. Imaging was performed with Veeco Innova Scanning Probe Microscope operating in 
tapping mode, with oxide-sharpened silicon probes (RTESPA-CP) at resonant frequency of about 
300kHz. Thanks to AFM analysis it was possible both to measure the pillars height, the distance 
between adjacent pillars and the pillar diameters and to correlate these values with the photoresist 
spinning parameters. For measuring nanofilm thickness by AFM scanning instead, the films, free-
suspended in water after sacrificial layer dissolution, were collected and dried onto a fresh silicon 
wafer. Thickness values were obtained by AFM cross-sectional analysis of nanofilm edge (SPMLab 
software version 7.20). The AFM scans were performed in three different areas of the same sample 
and on three different sample, in order to have a statistically significant data set.  
 
 
2.2.2  SCANNING ELECTRON MICROSCOPE (SEM) 
 
A SEM is a type of electron microscope that produces images of a sample by scanning it by means 
of a focused beam of electrons. The electrons interact with atoms in the sample, producing 
subsequently various signals that can be detected and that contain information about both the 
sample's surface topography and the composition. The electron beam is generally scanned in a 
raster scan pattern, and the beam's position is combined with the detected signal to produce an 
image. SEM can achieve resolution better than 1 nanometer. The most common mode of detection 
is by secondary electrons emitted by atoms excited by the electron beam. The number of secondary 
electrons is a function of the angle between the surface and the beam. By scanning the sample and 
detecting the secondary electrons, an image displaying the tilt of the surface is created. All samples 
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must be of an appropriate size to fit the specimen chamber and for conventional imaging in the 
SEM, specimens must be electrically conductive, at least at the surface, and electrically grounded 
to prevent the accumulation of electrostatic charge at the surface. Nonconductive specimens in fact 
tend to charge when scanned by the electron beam, and especially in secondary electron imaging 
mode, this causes scanning faults and other image artifacts. They are therefore usually coated with 
an ultrathin coating of electrically conducting material, deposited on the sample either by a low-
vacuum sputter coating or by high-vacuum evaporation. An alternative to coating for some 
biological samples is to increase the bulk conductivity of the material by impregnation with osmium. 
Nonconducting specimens may be imaged uncoated using environmental SEM or low-voltage mode 
of SEM operation. For SEM, a specimen is required to be completely dry, since the specimen 
chamber is at high vacuum. Before SEM analysis, the samples were gold-sputtered (25 mA, 60 
seconds) in order to supply a conductive coating to the specimen. SEM images were obtained by 
using a EVO MA15 SEM (Zeiss, Germany) equipped with LaB6 source and working at 10kV 
accelerating voltage. The samples were scanned with different magnifications: 1.11 KX, 4.00 KX, 
13.00 KX and 30.00 KX. 
 
 
2.2.3.  NANOFILM MECHANICAL PROPERTIES 
 
The mechanical properties of the PLA nanosheets were characterized by the Strain-Induced Elastic 
Buckling Instability for Mechanical Measurement (SIEBIMM) technique. The SIEBIMM test is based 
on the buckling metrology and allows the calculation of Young's modulus for polymeric nanosheets 
[51]. The elastic modulus can be calculated by measuring the buckling wavelength of the nanofilm 
collected on a mechanically compressed or stretched matrix. A free-standing PLLA nanosheet was 
collected from water onto a prestretched (3% strain of the original size) PDMS slab (1.5 cm x 4.0 
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cm). The configuration of the system used to perform SIEBIMM tests is shown in Figure 2.6, 2.7 and 
2.8. 
 
 
Figure 2.6: PDMS slab with its of the original size on a silicon wafer having a length that is 103%  strain of thePDMS slab 
length. 
 
 
Figure 2.7: Set up of the system used to perform the SIEBIMM test in the non-prestretched PDMS slab configuration, 
clamped at one side.  
 
 
 
 
Figure 2.8: Set up of the system used to perform the SIEBIMM test, after stretching the PDMS slab of the 3%  respect to 
its original size, and clamping the correspondent side in order to keep it stretched. 
 
The prepared sample was dried in a desiccator overnight prior to the SIEBIMM test. Then, the strain 
of the PDMS substrate was relaxed, producing a relative compression of the PLA nanosheet and 
61 
 
generating a characteristic corrugation. The wavelength (λ) of the buckling pattern on the PLLA 
nanosheet was analyzed using an optical microscope (Hirox KH7700 digital microscope, Hirox Co 
Ltd., Tokyo, Japan ), equipped with a MX(G)-10C zoom lens and OL-700II objective lens. Three 
samples were analyzed and for each sample ten images relative to different areas and obtained with 
different magnifications were acquired. 
Then, the Young's modulus () of the PLLA nanosheet was obtainedby the following formula: 
 = 3 ∗ 	
 ∗ 1 −  1 − 
⁄ ∗  2⁄ ∗  ∗ ℎ 
 
 
where: 

 = 1.8   Young's modulus of the PDMS slab 
 = 0.33   Poisson's ratio of PLLA nanosheet 

 = 0.5    Poisson's ratio of PDMS slab 
 
2.2.4.  PERMEABILITY TESTS: 
 
The permeability coefficient K of the porous nanofilms refers to water static capacity to pass 
through the membrane. Its evaluation is based on the measure of the liquid filtered through the 
nanofilm at different time-points. During the whole duration of the experiment the volume of the 
liquid, and consequently the pressure exerted on the nanofilm surface, was maintained constant. 
The evaluation of microporous nanofilms permeability found its theoretical motivations in the 
Darcy's law: 
" = # ∗ $ %⁄  ∗ & − ' (⁄  
where: 
Q= flow rate 
62 
 
A=surface available for the transfer of the filtered fluid 
µ=fluid viscosity 
Pb,Pa = pressures measured in correspondence of two sections 
 
The flow rate Q was calculated by means of the following formula: 
" = 1 )⁄  ∗ *+ ,⁄  
 
*mliquid mass filtered during the time unit 
) water density  
, time duration to measure the liquid filtered through the nanofilm 
" flow rate 
 
The pressure gradient is expressed by the following formula: 
&  '  *  ) ∗ - ∗  
 
* hydrostatic pressure 
) water density 
 height of the hydrostatic volume exerting a constant pressure on the nanofilm surface. 
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Figure 2.9: Lateral view of the set up of the system used to perform permeability tests. 
 
 
Figure 2.10: Upper view of the set up of the system used to perform permeability tests. 
 
As shown in the Figure 2.9 and 2.10, the experimental set up used to perform permeability tests 
was composed of: 
• A petri, where the liquid, filtered through the permeable nanofilm, was collected. 
• An insert having an inner diameter of about 6.5 mm. 
• An holder in PDMS which permitted hydraulic sealing and minimized fluid losses. 
• A support base, shown in figure 2.10, designed by means of Solidworks, which allowed to 
maintain in a fixed and pre determined mutual position the nanofilm, respect to the petri, 
where the liquid filtered was collected. 
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Figure 2.11: Solidworks design of the support base. 
 
 
The procedure consisted of the following phases: 
• The free-standing PLA nanofilm was collected from water on the insert. 
• A thin layer of PDMS 1:9, reticulating overnight at room temperature, was introduced 
between the two holder parts in order to enhance hydraulic sealing and to minimize fluid 
losses. 
• The insert was later embedded within a PDMS holder, having a proper shape and aimed at 
maximizing the hydraulic sealing. 
• Finally, the nanofilm was chemically treated with ethanol (40% in water ), for 15 minutes 
before performing permeability tests. 
 
Permeability was quantified by measuring the liquid filtered through the nanofilm at different 
time intervals, listed in Table 2.4: 
 
 
TIME INTERVAL [s] 
2 
3 
5 
7 
8 
10 
13 
14 
15 
20 
60 
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                 Table  2.4: Time intervals relative to permeability tests. 
 
During the whole duration of the experiments, the pressure exerted by the volume of water, equal 
to 1 ml, was maintained constant. The time intervals were referred to a reference baseline, 
corresponding to the instant in which the fluid started to flow through the membrane. 
 
2.2.5.  STUDY OF FITC PS NANOPARTICLE PASSAGE THROUGH THE 
PERMEABLE NANOFILM: 
Polystyrene Nanoparticles labelled with FITC-PS were used in order to investigate and characterize 
the passage of nanoparticles through the porous nanofilm. The choice of FITC-PS nanoparticles is 
related to the possibility to prepare and analyze samples using spectrophotometer. Moreover each 
sample can thus be analyzed step by step avoiding any problem of storage. FITC-PS (0.2 mg/ml in 
Eagle’s Minimum Essential Medium, EMEM, containing 2% of FBS)  of 200 nm in diameter were 
tested (Polysciences) because they are very easy to detect using a spectrofluoremeter. In order to 
prevent the possibility to form cluster in water, the Nanoparticles were dispersed in a 2% Fetal 
Bovine Serum (FBS) solution. FITC-PS nanoparticles are characterized by an excitation peak at about 
441 nm and an emission peak at 486 nm. 
The experimental procedure consisted of the following phases: 
• FITC-PS nanoparticles were at firts sonicated for 10 min in order to make the solution 
homogeneous. 
• Sonicated nanoparticles were later dispersed within an EMEM solution, containing 2% of 
FBS, at a concentration of 0.2 mg/ml. 
• Before quantifying nanoparticle passage, the correlation between the absorbance and the 
concentration of the fluorescent compound was estimated in order to obtain the calibration 
curve. The calibration curve provides a linear fitting of the data, over a range of nanoparticle 
concentration from 0.001 mg/ml to 1 mg/ml (suspended in EMEM containing 2% of FBS).  
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The nanoparticle concentrations analyzed are listed in Table 2.5: 
NANOPARTICLES CONCENTRATION 
[mg/ml] 
1 mg/ml 
0.1 mg/ml 
0.05 mg/ml 
0.01 mg/ml 
0.005 mg/ml 
0.001 mg/ml 
  Table  2.5: Nanoparticle concentrations within the EMEM solution. 
 
The absorbance corresponding to the set of concentrations was evaluated by means of 
FLUOstar Omega spectrofluoremeter. 
• PLA nanofilm was collected from water and blocked within the two parts of the Teflon 
holder. The holder was placed within a well of a 6-well multiwell plate. Volumes of 3 ml and 
1 ml of EMEM solution containing 2% of Fetal Bovine Serum (FBS) were added below and 
above the nanofilm, respectively. The samples, having a volume of 100 µl, were taken and 
analyzed by means of FLUOstar Omega spectrofluoremeter, at different time-points, in 
order to quantify the amount of nanoparticles filtered through the nanofilm for different 
time intervals. The timetable followed to take the samples is listed in Table 2.6: 
 
 
SAMPLING TIMETABLE 
10 minutes 
30 minutes 
1 hour 
2 hours 
4 hours 
6 hours 
              Table  2.6: Timetable followed to analyze the samples. 
 
The analysis of the amount of nanoparticles passed through the nanofilm at different time-points 
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allowed to evaluate the transport kinetics of nanoparticles and to demonstrate the non deviousness 
of nanofilm pores. In particular, the percentage of nanoparticles passed, during a time interval, 
through the nanofilm respect to their initial concentration was correlated to the sampling time-
points.  
 
2.3  DESIGN OF A HOLDER FOR CELL CO-CULTURE: 
A further step of the work consisted in the development of a Teflon holder, designed to allow cell 
co-culture in correspondence of the opposite sides of the porous polymeric nanofilm. Figure 2.11 
shows the holder structure. 
 
Figure 2.11 Teflon holder. 
The holder was designed in order to be inserted within a well of a 6 well-plate and to allow 
membrane blocking. The holder was composed of the following constituents: 
• A circular support base having two cylindrical columns, which allow holder insertion and 
blocking in a determined position; 
• Two parts connected by means of M2 nylon screws; 
• Two rectangular handles, which allow holder manipulation, repositioning and rotation.  
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2.4  CELL CULTURES: 
2.4.1  INTESTINAL EPITHELIAL CACO-2 CELLS: 
Caco-2 is an established cell line of heterogeneous human epithelial colorectal adenocarcinoma 
cells. Although derived from a colon carcinoma, when cultured under specific conditions the cells 
become differentiated and polarized such that their phenotype, morphologically and functionally, 
resembles the enterocytes lining the small intestine. Caco-2 cells express tight junctions, microvilli, 
and a number of enzymes and transporters that are characteristic of such enterocytes. When 
looking at Caco-2 cell cultures microscopically, it is evident even by visual inspection that the cells 
are heterogeneous. Caco-2 celle are most commonly used not as individual cells, but as confluent 
monolayer. When cultured in this format, the cells differentiate to form a polarized epithelial cells 
monolayer that provides a physical and biochemical barrier to the passage of ions and small 
molecules. The Caco-2 monolayer is widely used across the pharmaceutical industry as an in vitro 
model of the human intestinal mucosa to predict the absorption of orally administered drugs. 
 
2.4.2 CACO-2 CELLS CULTURE PROTOCOLS: 
Seeding protocol 
Caco-2 cells seeding protocol consisted of the following phases: 
• Removal of the culture medium where Caco-2 cells were previously suspended 
• Washing the cells with PBS in order to remove any residual of culture medium 
• Addition of a volume of 3 ml of trypsin and further treatment in incubator at 37°C 
• Cells Re-suspension in 3 ml of culture medium 
• Centrifuging for 5 min at 900 rpm 
• Supernatant removal 
• Re-suspension in 1 ml of culture medium and subsequent cell counting by means of 
Trypan Blue 
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• Cell seeding, on the PLA nanofilm blocked within the holder, at a cell density of 40000 
cells/cm², corresponding to 50000 cells cultured on each nanofilm. 
• Addition of culture medium volumes of 5 ml and of about 1 ml respectively under and above 
the nanofilm. 
 EMEM culture medium was substituted with fresh medium every three days. Culture medium 
removal was performed by  taking away the volume of medium which was at firts on the nanofilm and  
subsequently under the nanofilm. Volumes of 5 ml and 1 ml of fresh EMEM culture medium were  
added, respectively, below and above the nanofilm, respectively. 
Fixing with paraformaldehyde (PFA)  protocol 
Paraformaldehyde is the polymerization product of formaldehyde with a typical degree of  
polymerization of 8-100 units. Once paraformaldehyde is depolymerized, the resulting formaldehyde  
is commonly used as a fixative for microscopy and histology. The fixing protocol by the use of PFA  
consists of the following phases: 
• Removal of the culture medium where Caco-2 cells were suspended 
•  Washing the cells with PBS in order to remove any residual of culture medium 
• Addition of volumes of PFA equal to 3 ml and 1 ml, respectively under and on the 
nanofilm blocked within the holder, at room temperature for 20 minutes. 
• PFA removal. 
• Washing the cells with PBS. 
• Washing the cells with PBS a second time and leaving the cells dispersed in PBS at 4 °C. 
 
Cell staining 
• Cell permeabilization with 10 % Triton X-100 in PBS for 15 min. 
•  Rinsing two times with PBS, and saturation with 10 % goat serum (Invitrogen,Carlsbad, 
CA, USA) for 60 min.  
• Samples were then provided with a staining solution constituted by red fluorescent phal-
loidin (λem 633 nm Sigma Aldrich), able to stain F-actin in red and DAPI to stain nuclei in 
blue.  
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• After 30 min of incubation at room temperature, the solution was removed and the sam-
ples were rinsed 3 times with PBS.  
• Fluorescent samples were then inverted, mounted on glass slides, and imaged with a con-
focal fluorescence microscope (LSM 510 Meta, Carl Zeiss, Oberkochen, Germany).  
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3.  EXPERIMENTAL RESULTS: 
 
3.1  DEVELOPMENT OF POROUS NANOFILMS 
 
3.1.1  MICROFABRICATION TECHNIQUE BASED ON SPIN COATING AND SALT 
LEACHING 
 
The firts attempt to develop porous nanofilm was based on spin coating deposition on a silicon 
wafer, previously coated with a water-soluble sacrificial layer, of a polymeric solution containing a 
disperse phase of porogen particulate and further salt leaching in deionized water. 
 
POROGEN CHARACTERIZATION 
The porogen was characterized, in terms of quantification of grain size by SEM analysis of the 
porogen particles and the timing of the sifting phase was correlated to the resulting grain size.  SEM 
analysis in fact allowed to estimate grain dimensions corresponding to the different sifting timing 
tested. Table 3.1 schematizes the correspondence between sifting timing and the resulting grain 
size. 
 
SIFTING TIMING 
[min] 
5 10 15 20 
GRAIN SIZE 
[μm] 
20 15 10 5-10 
 
Table 3.1: Schematization of the grain size as a function of different sifting timing. 
 
The grain size decreased by increasing the sifting timing and the minimum porogen size achieved 
was 5-10 μm. In principle, this size was considered acceptable for our purposes. In fact, we aimed 
at producing pores in the membrane with a diameter of 1-10 μm to assure a relatively high film 
porosity, but preventing at the same time the passage of entire cells through the membrane (a 
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maximum diameter of 10 μm was thus identified, for the pores).  
 
SEM ANALYSIS OF PLGA NANOFILMS 
 
SEM images of PLGA nanofilms, obtained by spin coating and salt leaching, were acquired and 
analyzed (Figure 3.1 and Figure 3.2). In Figure 3.1 represents the areas correspondent to the edges 
of the nanofilm, whereas Figure 3.2 is relative to the central part of the membrane. It can be seen 
from the images that the external part of the membrane (close to its edge) is characterized by a 
certain porosity, with pore diameters mathing with the porogen size (5-10 μm). However, the 
central part of the nanofilm, corresponding to the majority of its area, is not porous.  
 
Figure 3.1: SEM images of an area correspondent to one edge of the nanofilm. 
 
Figure 3.2: SEM images of an area correspondent to the cental part of the nanofilm. 
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In fact, the force due to viscous friction did not allow a homogeneous distribution of the porogen 
within the nanofilm, because of both porogen grain dimensions and of the nanometric thickness of 
the resulting film. Centrifugal force was responsible for a prevalent porogen distribution in 
correspondence of the nanofilm borders, which were consequently porous, whereas the central 
part of the film was not porous. A scheme representing the spin-coating deposition process and the 
inhomogeneous porogen distribution is reported in Figure 3.3.  
 
Figure 3.3: Schematics concerning to porogen distribution before and after the spin-coating phase. 
 
 
Taking into account the above-mentioned considerations, the technique was not considered an 
effective means to achieve porous nanofilms. A possible solution to overcome this problem would 
be to reduce the grain size, thus allowing the porogen to lay completely inside the polymer solution 
during spin coating procedure. In the literature, there are some examples of porous polymeric films 
obtained by using salt leaching technique [48, 49, 50] (Figure 3.4 , 3.5) 
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Figure 3.4: SEM photomicrographs of PCL porous scaffolds generated after selective extraction of (a) and (b) 50% NaCl; 
(c) and (d) 60% NaCl; (e) and (f) 70% NaCl after dissolution of PEO and NaCl. 
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Figure 3.5: SEM micrograph of a porous PDLLA structure prepared by compression moulding and salt leaching of mixtu-
res of PDLLA and salt particles.  
 
However, these studies were focused on rather thick films, or the authors used really small 
porogens. For example Tran et al exploited the principles of crystallization to precisely control the 
porogen, sodium chloride, crystal sizes and thus obtained a reduction of salt particles diameter up 
to about 1.18 μm. Since we had not the possibility to achieve such porogen size with a simple and low 
cost technique (that is one of the Thesis purposes), we discarded salt leaching technique.  
 
3.1.2  MICROFABRICATION TECHNIQUE BASED ON PHOTOLITHOGRAPHY 
Patterned mold characterization 
 
In order to establish the optimal photo-polymerization parameters, the topograpy of the patterned 
mold was evaluated for different spin coating parameters, by using AFM scans in tapping mode 
(Table 3.2): 
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SPINNING SPEED 
[rpm] 
PILLAR HEIGHT 
[m] 
DISTANCE BETWEEN  
PILLARS 
[μm] 
PILLAR 
DIAMETER 
[μm] 
1500 1.50 ± 0.10 μm 4.95 ± 0.45 μm 4.94 ± 0.43 μm. 
2000 1.12 ± 0.15 μm 3.75 ± 0.40 μm 6.07 ± 0.35 μm. 
2500 0.85 ± 0.20 μm 5.36 ± 0.43 μm 4.49 ± 0.45 μm. 
3000 0.75 ± 0.17 μm 4.90 ± 0.38 μm 4.94 ± 0.30 μm. 
Table 3.2: Patterned molds characterization for different spinning speeds. 
 
Table 3.2 shows that the pillar height decreased when the spin coating speed increased. This 
consideration is coherent with the theoretical expected results. This analysis allowed the selection 
of the most suitable spin-coating set of parameters in relation to the aim of the work. The selected 
spinning speed was 1500 rpm in order to obtain the highest pillars. This allowed to obtain pores 
with a uniform diameter (see the following sections ), because the membrane thickness to be used 
was lower than the height of the pillar in correspondence of which its diameter started to change, 
due to microfabrication defects (non perfect UV exposure, minimal but existing gap between the 
mask and the wafer during the exposure process, etc. ) 
Figure 3.6 shows the structure of the patterned molds, obtained by using such spin velocity. 
 
 
Figure 3.6: 3D topography of a mold obtained by using 1500 rpm as spin velocity (left image ) and AFM height profile, 
corresponding to a line on the 2D scan (right image ). 
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Nanofilm characterization 
Nanofilm thickness vs. spin coating speed 
 
Once the mold was obtained, the thickness of the resulting film was measured by AFM scanning in 
tapping mode, and correlated to the spin coating parameters in order to optimize film thickness 
(Table 3.3 and Figure 3.6 ) 
SPINNING SPEED [rpm] AVERAGE THICKNESS [μm] STANDARD DEVIATION [%] 
 
3000 0,92 4,73 
4000 0,71 8,40 
5000 0,54 5,15 
6000 0,44 6,08 
7000 0,38 3,14 
Table 3.3: Nanofilm thickness characterization for different spinning speeds. 
 
Figure 3.7: Nanofilm thickness vs spin-coating speed. 
 
The results confirm the theoretical expectations: nanofilm thickness decreased as spin coating 
speed increased. This is due to the increase of centrifugal force for higher speeds. The results match 
with previous literature data, which report similar behaviours [51,52]. Experimental results 
demonstrated that PLA spin-coating deposition on patterned molds, determined a resulting porous 
nanofilm which proved to be thicker than the non porous one obtained by spin coating on flat silicon 
wafers. The higher thickness of porous nanofilms, spin-coated on patterned molds, could be 
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reasonably due to the presence on the coated substrate of the cylidrical pillars, which obstructed 
PLA homogeneous deposition.  
Moreover the correlation between the resulting film thickness and the spin coating speed can be fit 
with an exponential curve (Figure 3.5). It is possible to establish an analytical relation between spin 
coating speed and film thickness, in order to develop films with the desired thickness. Starting from 
this characterization, spin coating parameters were set at 6000 rpm for 20 seconds, in order to 
obtain nanofilms characterized by both  a regular and pre-determined porous pattern. Moreover 
polymer film could be actuable by cardiac cells contractile force, thanks to the small thickness. The 
choice of these spin coating parameters allowed in fact to obtain nanofilms characterized by an 
average thickness of about 440 nm.  
Nanofilm morphology and mechanical properties 
SEM images, obtained at different magnifications (Figures 3.6, 3.7 and 3.8), demonstrate the regular 
porous pattern characterizing PLA nanofilms. 
 
Figure 3.8: SEM image of a porous nanofilm, obtained with 1.11 KX magnification. 
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Figure 3.9: SEM image of a porous nanofilm, obtained with 4.00 KX magnification. 
 
 
 
Figure 3.10: SEM image of an individual pore obtained with 30.00 KX magnification. 
 
The SIEBIMM test, based on the buckling metrology, allowed the calculation of nanofilm Young's 
modulus. The Young’s Modulus of the PLA porous nanosheets was estimated equal to 2.64 ± 0.37 
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GPa. Figure 3.11 shows an Hirox image of the buckled nanofilm surface, with some measurements 
reported.  
 
Figure 3.11:HIROX image of the buckled nanofilm surface. 
 
The elastic modulus of highly elastic polymeric materials can vary from 7 MPa, up to 4 GPa in the 
case of stiffer polymers. In particular, PLA nanofilms have been already analyzed by Fujie et al, in 
terms of mechanical properties measured by SIEBIMM technique [51]. Here, the authors showed 
that nanofilms with a comparable thickness to the ones we obtained, showed a Young’s modulus of 
6.6 ± 1.7 GPa. The lower values we obtained are probably due to the presence of the pores.  
The PLA porous nanofilms we obtained are rather stiff and resistant towards traction. In terms of 
mechanical properties, in the case of the application of a traction stress, porous PLA nanofilms 
showed a Young's modulus similar to the one of polycarbonate. Polycarbonate in fact is 
characterized by an elastic modulus, in the case of traction stress, of 2.38 GPa. 
Nanofilm permeability and passage tests 
Porous nanofilms were also characterized in terms of permeability, in order to study their usability 
as an interface system. They showed a rather high hydraulic permeability and good hydraulic 
withstanding. Nanofilm permeability coefficient was estimated equal to 4.75 ∗ 10012 ± 0.5 m2. 
 Furthermore, FITC-PS nanoparticle passage tests were performed on PLA nanofilms in order to 
demonstrate that, thanks to the non deviousness of its pores, the membrane allows the transit of 
nanoparticles. The purpose was to overcome the limitations characterizing current commercially 
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available membranes, which instead entrap nanoparticles within their structure, thus not allowing 
their passage. Figure 3.12 represents nanoparticles passage percentage, respect to the initial 
amount as a function of the different sampling time-points.  
 
Figure 3.12: Nanoparticles passage percentage as a function of different time-points. 
 
The data trend underlines that the nanoparticles, able to pass through the porous nanofilms, 
increased over time. The scatter graph consists of an initial tract characterized by a high increase of 
the nanoparticle passage rate through the nanofilm. After the initial transient, the data trend 
increases more slowly and tends to a plateau value, of about 19 % respect to the initial amount of 
FITC-PS. 24 h after the beginning of the experiments about 19 % of nanoparticles was filtered 
through the porous nanofilm. As the nanofilm is characterized by a theoretical porosity of about 20 
%, 19 % of passage percentage means that almost all nanoparticles passed through the nanofilm 
pores and the residual quantity was not retained within the membrane, but was deposed on its 
surface. These results are very promising if compared to studies concerning nanoparticle passage 
through commercially available membranes. In the example proposed [53], in fact the commercial 
membranes used almost did not allow the transit of nanoparticles, in static conditions, whereas in 
the case of dynamic passage studies, in presence of fluid flow, 24 h after the beginning of the 
experiments only 12 % of the original nanoparticle weight succeded in passing through the 
membrane. 
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3.2  CELL CULTURE RESULTS 
3.2.1  INTESTINAL CACO-2 CELL CULTURE 
In order to use the polymeric nanofilm as an interface for cell culture within a biohybrid system, 
preliminary tests of cell compatibility were performed. Caco-2 cells were cultured on PLA non 
porous nanofilms in order to evaluate the interaction and the compatibility between the cells and 
the material. The preliminary adhesion tests for Caco-2 cells cultured on PLA nanofilms revealed a 
good cell-material interaction, as demonstrated by the DAPI images, shown in Figure 3.13, 3.14 and 
3.15. 
 
Figure 3.13: DAPI image (cell nuclei) of Caco-2 cells cultured on PLA nanofilms (4x magnification). 
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Figure 3.14: DAPI image (cell nuclei )of Caco-2 cells cultured on PLA nanofilms (10x magnification). 
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Figure 3.15: DAPI image ( cell nuclei) of Caco-2 cells cultured on PLA nanofilms, (20x magnification). 
These preliminary results, demonstrated that PLA nanofilms show a good biocompatibility and allow 
Caco-2 cell adhesion on their surface, that is a pre-requisite for the final envisioned application. 
Caco-2 cell cultures on PLA nanofilms were viable for up to 7 days. The cells  were fixed with PFA 
the third and the seventh day from  the beginning of the culture to monitor the temporal 
development of cell growth and adhesion. Figure 3.16 shows the images relative to Caco-2 cell 
culture ( fixed with PFA on the third day of culture) seeded on PLA nanofilms, blocked within the 
Teflon holder.  
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Figure 3.16: Caco-2 cell culture on PLA nanofilms, blocked within a Teflon holder, fixed with PFA in correspondence of the 
third day of culture.  
Figures 3.17, 3.18 and 3.19 instead show Caco-2 cells, seeded on PLA nanofilms placed on a glass 
slide and fixed with PFA on the third day of culture.  
 
 Figure 3.17: Caco-2 cell culture on PLA nanofilms, placed on a glass slide and fixed with PFA on the third day of 
culture.  
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Figure 3.18: Caco-2 cell culture on PLA nanofilms, placed on a glass slide and fixed with PFA on the third day of culture.  
 
 
 
 Figure 3.19: Caco-2 cell culture on PLA nanofilms, placed on a glass slide and fixed with PFA on the third day of 
culture.  
 
Figure 3.20: Caco-2 cell culture on PLA nanofilms, placed on a glass slide and fixed with PFA on the seventh day of culture. 
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Figure 3.21: Caco-2 cell culture on PLA nanofilms, placed on a glass slide and fixed with PFA on the seventh day of culture. 
 
The results showed a good biocompatibility of the porous PLA nanofilms with Caco-2 cell cultures, 
that were able to adhere, spread, proliferate and start to differentiate on such substrates.  
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4.  CONCLUSIONS AND FUTURE DEVELOPMENTS 
 
The objective of this Thesis was the design, development and characterization of a biomimetic 
system to be used as a tool to simulate the intestinal barrier in vitro and to study the cell-mediated 
passage of soluble and non soluble particles. The system proposed in this thesis is a biohybrid tool, 
based on a porous polylactid acid nano-membrane, which constitutes the interface between 
intestinal epithelial cell layer (Caco-2) and a self-beating muscle layer (mimed by cardiomyocites). 
The aim is to obtain an in vitro model, useful to test drugs, nanoparticles and other substances in 
terms of their toxic and/or therapeutic effects. The current research trend, aimed at engineering 
organs and tissues, is envisaged as a tool to complement or to replace tests on animals, widely used 
at present for toxicological analyses and drug testing. In addition to ethical concerns, in vivo tests 
are also characterized by long time durations and high costs, thus raising the need of effective in 
vitro alternatives. The in vitro tool developed in this thesis could be useful for the study of specific 
diseases related to dysfunctions in intestinal malabsorption mechanisms. The purpose of this work 
arises from the need to have a tool that allows to model the physiological and pathological features 
of the intestinal barrier and, on the other hand, the absorption mechanisms through it. Taking into 
account the intrinsic limitations of the traditional models and the lack of suitable technologies and 
procedures in the state-of-the-art, this works aims at:  
⦁ developing a ultra-thin polymeric membrane provided with highly regular pores (conferring 
high permeability to the system) and showing high biocompatibility, thus allowing the culture 
of intestinal Caco-2 cells and cardiomyocytes. This will allow, with few evolutions of the device, 
to replace monocultures with co-cultures of these cells; 
⦁ developing a biohybrid tool that would be able, in future evolutions of the system, to gene-
rate contractile movements which simulate in vitro the peristalsis of the intestine occurring in 
vivo. 
The device proposed in this Thesis mimics the intestinal barrier as a permeable selective interface 
by the use of engineered porous PLA nano-membranes. Muscle cells would stretch the supporting 
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membrane and subsequently actuate the overall device, thanks to their capability to develop 
contractile active forces. The use of cardiac cells would allow to neglect and remove the problems 
due to the need of external electrical stimuli to contract the muscular fibers and subsequently to 
the integration of biocompatible electrodes in the system. The development of porous nanofilms 
allowed to create a permeable interface between two cell types, intestinal epithelial cells and mucle 
contractile cells. The purpose was to obtain nanofilms characterized by both a regular and pre-
determined porous pattern and at the same time actuable by cardiac cells contractile force (thanks 
to the small thickness). PLA porous nanofilms, having a Young’s modulus of 2.64 ± 0.37 GPa, are 
thus rather stiff and resistant towards tractions stresses, they showed furthermore a rather high 
hydraulic permeability, good hydraulic withstanding and good permeability also to FITC-PS 
nanoparticle passage. Their capability to allow the passage of a consistent amount of nanoparticles, 
is an innovative potential in respect to the available commercial membranes, which entrap 
nanoparticles within and do not allow their transit in static conditions, without fluid flow. 
Preliminary tests of cell compatibility and viability were performed in order to evaluate the usability 
of the polymeric nanofilm as an interface for cell culture. The biological outcomes demonstrated 
that PLA nanofilms can be used within a biohybrid system, as they revealed a good cell-material 
interaction, allowing Caco-2 cells adhesion on their surface, that is a pre-requisite for the final 
envisioned application. The model proposed in this Thesis is a preliminary approach which tended 
to model the intestinal barrier in terms of both permeability and peristalsis. This prototype, could 
properly evolve in the future in a biomimetic device, more similar both from the morphological and 
from the functional point of view to the intestinal barrier in vivo. This could be obtaind by 
substituting self-beating cardiomyocytes with externally-stimulated smooth muscle cells, 
responsible for the actuation of the system, aimed at reproducing intestinal peristalsis. The co-
culture of intestinal epithelial Caco-2 cells and muscle cells on the opposite sides of the interface 
nanofilm, could allow to perform passage studies of drugs and nanoparticles in both static 
conditions and in the presence of fluid flow, in order to evaluate the cell-mediated transit of 
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compounds, to perform drug screening and nanotoxicology studies. 
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